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SUMMARY 
 
In this work, the genetically tractable Kluyveromyces lactis yeast has 
been used to study the molecular basis of Hailey–Hailey disease 
(HHD). This pathology, also known as familial benign chronic 
pemphigus, is a rare, chronic and recurrent blistering disorder, 
characterized by acantholysis. The genetics and pathophysiology of 
HHD have been linked to mutations in ATP2C1. The gene encodes for 
an adenosine triphosphate (ATP)-powered calcium channel pump and 
PMR1 is the yeast orthologue. Similarly to human HHD-cells, in yeast 
the loss of PMR1 promotes cellular toxicity caused by increased 
oxidative stress linked to the alteration of calcium homeostasis. By a 
functional suppression screening of yeast mutant with a cDNA library, 
we found that Glutathione S-transferase (GST), an important 
detoxifying enzyme, could be a candidate gene associated with Hailey-
Hailey disease. Expression of mammalian GST in Klpmr1 alleviated 
several defects; these include oxidative-stress toxicity, calcium 
alteration and mitochondrial dysfunction. Additionally, the discoveries 
made in yeast were validated in HHD-derived cells. Indeed, HHD-
lesional derived keratinocytes showed a decreased expression of GST 
gene when compared to non-lesional skin derived cells from the same 
patients. In parallel to the genetic screening, a drug screen was 
performed to find compounds with potential therapeutic effects for 
HHD treatment. Indeed, currently, there is no reported cure for HHD. 
For this reason, 131 FDA-approved natural compounds were screened 
for their ability to alleviate the calcium alterations and the oxidative 
stress of Kluyveromyces lactis pmr1 cells. The drug collection 
includes inhibitors, activators and antagonists acting on molecular 
targets involved in different signaling pathways. The initial screening 
system was based on the cell wall alterations of the pmr1∆ mutant, 
utilizing the chitin binding stilbene fluorescent brightener calcofluor 
white. In the first part of the screening 12 molecules resulted toxic, 
while 71% of the library molecules were ineffective and the remaining 
appeared to have a partial effect. Therefore, in a second round of the 
screening, these last compounds were evaluated at higher 
concentrations. Based on this, six molecules were selected for further 
analysis. Their effects on other defects of pmr1 mutant strain were 
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also evaluated, ranging from alteration of Ca
2+
 homeostasis to 
sensitivity to the ROS-generators menadione and H2O2, as well as the 
mitochondrial functionality. 
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INTRODUCTION 
 
1. Calcium homeostasis 
 
1.1. Calcium homeostasis in high eukaryotes 
 
Ca
2+
 ions have a  central role in cell signaling as a second messenger, 
regulating several cellular processes such as metabolism, cell 
proliferation, division and differentiation, gene transcription, muscle 
excitation-contraction, programmed cell death and neurotransmission 
(Berridge et al., 2003). To maintain Ca
2+
 homeostasis, the flow of Ca
2+
 
into and out of cells and organelles has to be precisely regulated. A 
network of Ca
2+
-transporters, -channels, -exchangers, -
binding/buffering proteins and -pumps are involved to control within 
the cell, the fluxes and concentration of Ca
2+
 (Krebs et al., 2015).  
 
 
 
1.1.1. Calcium buffers 
 
Once Ca
2+ 
enters in the cell, it is rapidly buffered by Ca
2+
 buffering 
proteins and the amount that escapes will then activate the targets of the 
signalling. In the cytosol there are the pure Ca
2+ 
buffers (parvalbumin, 
calbindins, and calreticulin) and the Ca
2+
sensors that   not only buffer 
calcium but also process its signal. The most important of them is 
calmodulin (CaM), which is expressed ubiquitously in cells (Faas et al., 
2011). It belongs to the family of EF-hand proteins and when it binds 
the Ca
2+
, it undergoes under conformational changes to contact the 
target proteins (Kawasaki et al., 1998).  
Also in the lumen of the intracellular stores, large amount of Ca
2+ 
is 
buffered by Ca
2+ 
binding proteins such as calsequestrin or calreticulin 
(Marenholz et al., 2004). 
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1.1.2. Calcium entry 
 
Several plasma membrane Ca
2+ 
channels allow the calcium enter in the 
cell (Fig. 1). These channels have been divided in three major groups: 
the voltage-gated channels (VOCs), the receptor-operated channels 
(ROCs), the store-operated Ca
2+
 entry channels (SOCEs). 
The VOCs are key transducers of membrane potential localized in the 
conductive cells. Their Ca
2+ 
selectivity is high and they can be divided 
in three subfamilies: Cav1, Cav2, and Cav3. The Cav1 subfamily 
initiates muscle contraction, secretion, regulation of gene expression, 
integration of synaptic signals, and mediates the L-type current. Cav2 
subunits are mainly responsible for the initiation of synaptic 
transmission at fast synapses. The Cav3 subfamily is important for the 
action potentials in cardiac myocytes and thalamic neurons (Catterall, 
2011).  
 
 
 
Fig. 1 Schematic representation of the different Ca
2+
 transport proteins of the plasma 
membrane and the main intracellular stores (Brini et al., 2013). 
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The second class of membrane Ca
2+ 
channels, ROCs, is activated by the 
interaction with ligands. For example, L-glutamate, the most important 
excitatory transmitter in mammalian brain, activates two classes of 
receptors, the ionotropic receptors (iGluRs) and the metabotropic 
receptors (mGluRs). The first are ligand-gated non-selective cation 
channels, while the second are coupled to G-proteins and they generate 
Ca
2+ 
signals through the activation of distinct downstream signaling 
cascades. 
The SOCEs are instead activated by the release of Ca
2+ 
from the 
endoplasmic reticulum (ER). They are composed by two elements: a 
Ca
2+
-binding transmembrane protein, STIM (stromal interacting 
molecule), that serves as sensor of calcium within the ER and a  plasma 
membrane store-operated channel composed by ORAI subunits(Gwack 
et al., 2007).  
When there is a depletion of calcium from ER, these two protein 
localized to the ER-PM junctions, coupled together to form the SOCE 
channel, thus generating a localized Ca
2+ 
influx (Luik,et al., 2006).  
TRPCs (transient receptor potential channels) instead contribute to 
change the intracellular Ca
2+ 
concentration either directly by acting as a 
calcium entry pathway, or indirectly by changing the membrane 
polarization that in turn may trigger the activation of different voltage-
dependent ion channels ( Montell et al., 2005; Gees et al., 2010). 
 
 
 
1.1.3. Intracellular calcium release  
 
The intracellular Ca
2+ 
Channels, are localized on the endo/sarcoplasmic 
reticulum (ER/SR) and the Golgi apparatus (GA) (Fig 1). The main two 
types of Ca
2+ 
receptors/channels in these compartments are the 
ubiquitous inositol 1,4,5-trisphosphate receptors (InsP3 R) and the 
ryanodine receptor (RyR), which is not present in all cell types (Chan et 
al., 2010). When the cell surface receptors are activated, the second 
messenger InsP3 is generated through the activity of phospholipase C 
and thus it releases calcium from the endoplasmic reticulum through 
the InsP3R (Taylor and Tovey, 2010). Cytosolic Ca
2+ 
is a co-agonist of 
the InsP3Rs, so that it strongly increases its activity at concentrations 
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up to about 300nM. By contrast, at higher concentrations it inhibits the 
receptor. Homologous to the IP3R is the Ca
2+
-release channel of the 
sarcoplasmic reticulum, the ryanodine receptor (RyR), which received 
its name due to the high affinity binding of the plant alkaloid ryanodine 
(Petegem, 2012). In muscle cells, the RyR is primarily located on the 
SR, in non-muscle cells it is expressed in the ER. This receptor is 
responsible for the excitation-contraction mechanism-mediated coupled 
with the voltage-dependent Ca
2+ 
channel dihydropyridine receptor 
(DHPR) located in the T-tubules of muscle cells. (Brini et al., 2013). 
 
 
 
1.1.4. Calcium pumps 
 
Ca
2+
-ATPases (pumps) are another class of protein that contribute to 
regulate calcium levels in the animal cells. They are divided in to three 
classes: the plasma membrane Ca
2+
-ATPase (PMCAs), the 
sarco/endoplasmic reticulum Ca
2+
-ATPase (SERCAs), and the 
secretory pathway Ca
2+
-ATPase (SPCA) that are in the Golgi 
membrane. Meanwhile, in the SERCA pumps there are two Ca
2+ 
binding sites (Clarke et al., 1990), the PMCA and SPCA pumps have 
only one, corresponding to site 2 of the SERCA pumps (Guerini et al., 
2000). 
They decrease the concentration of cytosolic Ca
2+ 
by exporting it to the 
external medium, or to the internal space of the vesicles of the 
reticulum and of the Golgi systems. The three pumps have a high 
affinity for calcium and belong to the superfamily of P-type ATPases 
(Pedersen and Carafoli, 1987), which conserve temporarily the energy 
liberated by the splitting of ATP in the form of an aspartyl phosphate in 
their reaction center. The affinity for calcium is particularly high in the 
SPCA pumps, which have Kds well below the concentration of Ca
2+
 in 
the cytosol at rest. This ensures that the Golgi vesicles will be always 
filled with calcium even in the absence of a calcium signalling 
activation. This is crucial, since Ca
2+ 
is required for the activity of 
enzymes within the Golgi vesicles, like the endoproteases that process 
the pro-hormones. Importantly, the SPCAs also transport Mn
2+
, which 
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is essential inside the Golgi vesicles for the O- and N-glycosylations of 
a number of proteins (Kaufman et al.,1994; Varki, 1998).  
The plasma membrane possesses also Na
+
/Ca
2+ 
exchangers (NCXs) 
with a low Ca
2+ 
affinity. The system belongs to the SLC8 (solute carrier 
family 8) that are particularly active in the cells of excitable tissues. 
NCX uses the energy of the electrochemical Na
+
 gradient to export 
Ca
2+
, with a transport stoichiometry of 3 Na
+ 
for 1 Ca
2+
 (Carafoli et al., 
2001). Since the operation of the NCX is electrogenic and voltage-
sensitive, it can reverse during cell activation and lead to the uptake of 
Ca
2+
into the cell (Blaustein and Lederer, 1999). Another member of the 
Na
+
/Ca
2+ 
exchanger superfamily is the NCKX, that also exchanges K
+
 
and it was first identified in the retina (Reilander et al., 1992).  
 
 
 
1.1.5. Other calcium transports  
 
As another important calcium store also mitochondrion possesses 
different calcium transporters (Fig. 2). Calcium mainly enters in this 
organelle by Ca
2+
 uniporter MCU that uptakes Ca
2+
 released from ER 
(De Stefani et al., 2011). Meanwhile, in the case of Ca
2+
 efﬂux, 
mitochondrial Na
2+
/ Ca
2+
 exchangers (NCLX) use the concentration 
gradient of Na
+
 across the inner membrane to cause the release of Ca
2+
 
back into the cytosol (Carafoli et al., 1974). The cycle is then 
completed thanks to the efﬂux of Na+ via the Na+/H+ exchanger (NHE) 
(Nicholls, 2005).   
Finally, acidic organelles, such as the acidic endosomes and lysosomes 
seem to be possible Ca
2+
 stores in mammalian cells (Fig. 2). Indeed, 
they possess Ca
2+
 - binding proteins, such as chromogranins and 
secretogranins, with a large Ca
2+
 - buffering capacity (Yoo et al., 2007) 
and they have also been reported to be able to release Ca
2+
 by canonical 
second messengers described for the ER/SR and the Golgi, like InsP3 
and ryanodine. The calcium uptake through this system appears to rely 
on the large proton gradient established by the vacuolar proton pump 
V-ATPase (Patel and Docampo, 2010).  
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Fig. 2 Schematic representation of Ca
2+
 handling by mitochondria, endoplasmic 
reticulum (ER), Golgi apparatus, and acidic stores (Brini et al., 2013).  
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1.2. Calcium regulation in yeast 
 
As in mammalian cells, calcium signalling regulates in yeast a wide 
variety of cellular processes including cell-cycle progression, mating, 
protein processing, responses to hypotonic stress, maintenance of 
intracellular pH, nutritional and metabolic signalling.  
Furthermore, yeast cells also bear homologs of the major components 
of the mammalian Ca
2+
 signalling, including channels, co-transporters 
and pumps. Thus, it has proven to be a powerful tool to elucidate the 
molecular aspects of several Ca
2+
-related processes of higher 
eukaryotes (D’hooge et al., 2015).  
 
 
 
1.2.1. Calcium influx 
 
Extracellular calcium can enter the cytosol through different pathways 
(Fig.3). The best characterized is the high affinity, low capacity influx 
system, homologue of voltage-gated Ca
2+
 channels. It is based on two 
Mid1p and Cch1p proteins that assemble on plasma membrane to form 
a channel (Paidhungat and Garrett 1997), but evidence also suggests 
that they may function independently (Locke et al. 2000). Both 
assembled on plasma membrane, Cch1 (Calcium Channel Homologue) 
was primarily identiﬁed as a Ca2+ channel homologue of a voltage-
gated calcium channel from higher eukaryotes (Paidhungat and Garrett 
1997); while Mid1 (Mating pheromone-Induced Death) was identiﬁed 
in a screen for mutants defective in survival after mating differentiation 
and in calcium uptake (Iida et al. 1994). Later, Mid1 was classiﬁed as a 
stretch-activated channel, with similarities to higher eukaryotes SA-Cat 
channels (Kanzaki et al. 1999). Mid1 was also found in ER as a 200-
kDa oligomer by covalent cystein bounding (Yoshimura et al. 2004). 
Importantly, mid1cch1 double mutants are indistinguishable of single 
mutants, this and physiological data indicating that Mid1 and Cch1 
might be components of a unique yeast Ca
2+
 channel (Paidhungat and 
Garrett 1997). Both proteins together could act as a voltage-gated Ca
2+
 
channel (VGCC) becoming activated in response to depolarization 
(Catterall 2000; Cui et al. 2009a). The presence of mating pheromone 
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or depletion of manganese from the medium (Paidhungat and Garrett 
1997), depletion of calcium from the ER (Bonilla et al. 2002), alkaline 
environment (Viladevall et al. 2004), osmotic or saline stresses 
(Matsumoto et al. 2002; Peiter et al.2005; Viladevall et al. 2004), are 
signals that trigger calcium entry in the cell through the Mid1/Cch1 
channel.  
Based on calcium tolerance experiments and mathematical models, two 
transport systems have been postulated (Cui and Kaandorp 2006). 
These transporters or pumps have been termed as transporter X and 
transporter M and their activities could be modulated by extracellular 
Mg
2+.
 
 
 
 
1.2.2. Calcium storage 
 
Excessive free calcium is toxic for yeast cells because it may interact 
with numerous proteins or oligomolecules (ie. polyphosphate-derived 
compounds such as NTPs) in the cytoplasm. Thus, the excess of 
calcium is rapidly eliminated by the activity of different Ca
2+
 pumps 
and exchangers (Cui et al. 2009b).  
Vacuole is the main calcium store in the yeast and it contains 
approximately ≥95% of total cellular Ca2+ (Cui et al. 2009a). Calcium 
enter in the vacuole mainly through two principal transporters: the P-
type ATPase Pmc1 pump (Cunningham and Fink 1994) and the Ca
2+
 
/N
+
 exchanger, Vcx1 ( Miseta et al. 1999).  
Pmc1 is conserved in nearly all fungi and is closely related to the 
PMCA-family of plasma membrane Ca
2+
-ATPases found in animals. 
However, Pmc1 has not been observed in the plasma membrane of S. 
cerevisiae but only in the vacuole membrane (Marchi et al., 1999). 
When intracellular calcium levels increased, the expression of PMC1 is 
up-regulated (Marchi et al. 1999) and loss of Pmc1 function reduces the 
amount of non-exchangeable calcium in the vacuole. However, 
inactivation of calcineurin restores calcium sequestration in the vacuole 
of a null pmc1 mutant, indicating that tolerance of null PMC1 mutants 
to calcium is dependent on the activity of Vcx1, which, on the other 
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hand, it is dependent on calcineurin activity (Cunningham and Fink 
1996).  
The vacuolar Ca
2+
/H
+
 exchanger of S. cerevisiae Vcx1, also known as 
Hum1 for “high copy number undoes manganese”, was identified for 
its ability to confer tolerance to high Ca
2+
  and Mn
2+ 
concentrations 
when it is overexpressed (Pozos et al. 1996). The contribution of Vcx1 
to vacuolar Ca
2+
 uptake and tolerance are markedly increased when 
calcineurin is inactivated, indicating that calcineurin negative controls 
Vcx1 activity in vivo, but the mechanism of this inhibition is not yet 
known (Cunningham and Fink, 1996; Pozos et al., 1996) 
Furthermore, biochemical data using puriﬁed vacuoles and vacuole 
membrane vesicles have evidenced that Ca
2+
 transport activity of Pmc1 
and Vcx1, more dramatically for the latter, depends on the pH gradient. 
Calcium uptake is promoted when the interior of these compartments is 
acid and lost when it is alkaline. This optimal acidiﬁcation of vacuoles 
is maintained by the vacuolar H
+
 V-ATPase activity (Dunn et al. 1994).  
 
 
 
Fig. 3 Main transport elements of calcium in S. cerevisiae (Espeso, 2016). 
 
 
 
The Golgi apparatus, together with vacuole, is another important 
calcium store in yeast cells. Calcium is concentrated in this 
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compartment mainly through the activity of Pmr1, a Ca
2+
/Mn
2+
 pump 
homologue to the mammalian SPCA1.  Pmr1 localizes primarily to the 
Golgi complex like its homologs in mammals (Antebi and Fink, 
1992;Uccelletti et al., 1999), and therefore supplies Ca
2+
 and Mn
2+
 to 
the endoplasmic reticulum during its early biogenesis or through 
vesicle mediated trafficking in the retrograde direction from the Golgi 
complex.   
As in high eukaryotic cells, the transport of calcium and manganese to 
ER is also important for the proper functioning of ER, as for the normal 
secretion of proteins, protein maturation and/or degradation. Thus, 
mutants of S. cerevisiae that lack the Pmr1 exhibit a range of secretion 
defects, as well as defects in N- and O-glycosylation (Durr et al. 1998). 
 
 
 
1.2.3. Calcium release 
 
About 10% of the total intracellular calcium can be released back to the 
cytoplasm and it is designated as the “exchangeable” pool of calcium 
(Cunningham and Fink 1994). 
In vacuoles, calcium is present in two forms: a free and a non-usable 
pool. The latter is designated as “non-exchangeable” since calcium is 
associated to polyphosphates. The concentration of free calcium in 
vacuoles is about 30 M meanwhile the total calcium was estimated at 
the millimolar range (2 mM) (Dunn et al. 1994). However, this reduced 
free-calcium pool can be returned to the cytoplasm when required.  
The Ca
2+
 released from the vacuole occurs mainly via Yvc1. This 
channel is well conserved among fungi and it  is most closely related to 
the TRPC-family of Ca
2+
 channels that are well characterized in 
animals (Palmer et al., 2001). Yvc1 is localized almost exclusively to 
the vacuole membrane of S. cerevisiae and its activation is important in 
response to hyperosmotic shock, reducing agents, and it has the ability 
to pass Na
+
 and K
+
 in vitro in addition to Ca
2+
 (Dong et al., 2010). 
These properties suggest that Yvc1 may be capable of rapidly releasing 
cationic osmolytes into the cytoplasm upon hypertonic shock to 
contrast the cytoplasmic dehydration and osmotic imbalance.  
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For the Ca
2+
 release from ER and Golgi, the current hypothesis is that 
calcium ions leave these compartments by exocytosis. Indeed, the 
genes coding for inositol tri-phosphate (IP3) receptors and ryanodine 
receptors, RyR, are absence in the yeast genome and calcium 
transporters for this activity are unknown. Moreover, it has been 
measured that when the calcium concentrations in Golgi and ER exceed 
their resting levels of 300 M and 10 M, respectively, the ion will be 
secreted along with the canonical secretory pathways (Pinton et al. 
1998; Aiello et al. 2002).  
 
 
 
1.2.4. Calcium signalling 
 
Yeast cells are able to adapt to large and rapid modiﬁcations in 
environmental calcium, ranging from a low concentration of 1M to 
more than 100 mM (Anraku et al. 1991) due to the activation of a 
signaling cascade leading to the modiﬁcation of the gene expression. 
When calcium enters in the cytoplasm, upon elevation of extracellular 
levels, one of the targets is the small and essential sensor protein 
calmodulin, Cmd1 (Cyert, 2001). Calmodulin has many roles in the 
yeast cells that can be classiﬁed into calcium independent and 
dependent functions (Davis et al. 1986). Among the calcium-dependent 
roles, one it is to activate the protein phosphatase 2B calcineurin (Fig. 
4). In S. cerevisiae calcineurin is composed of a catalytic subunit, the A 
subunit encoded by either CMP2 or CNA1 isoforms (Cyert et al. 1991), 
and the regulatory B subunit encoded by CNB1 (Cyert and Thorner 
1992). Activity of Cnb1, and subsequently of the calcineurin, is 
modulated by the -arrestin Aly1 (O’Donnell et al. 2013) and through 
myristoylation (Connolly and Kingsbury 2012) in response to a 
reduction in calcium signal.  
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Fig. 4 Calcium signaling cascade in S. cerevisiae. (a) The calmodulin/calcineurin 
cascade towards activation of the transcription factor Crz1. Among Crz1 targets are 
the genes PMR1 and PMC1, coding for the P-type ATPases, and (b) calcineurin 
regulators RCN2 and RCN1 (Espeso, 2016). 
 
 
 
The calcineurin phosphatase may have numerous targets and one of 
these is the Crz1 transcription factor (Stathopoulos and Cyert 1997). 
Crz1 is a three zinc ﬁnger transcription factor that is inactivated and 
activated in a cyclic phosphorylation/dephosphorylation process (Dalal 
et al. 2014). 
Crz1 mediates yeast tolerance to high concentrations of different 
cations, alkalinity and other types of stresses (Cyert 2003). When Crz1 
is in its phosphorylated state, it is recognized by the exportin Msn5p 
that brings it in the cytoplasm (Boustany and Cyert 2002). After 
calcineurin dependent dephosphorylation in response to an elevation of 
the cytoplasmic calcium concentration, the nuclear import signal of 
Crzy is recognized by the nuclear transporter Nmd5 and the 
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transcription factor is translocated in nucleus (Polizotto and Cyert 
2001).  
In the nucleus Crz1 will bind to specific DNA sequences known as 
CDREs (Calcineurin-Dependent Regulatory Elements) present in the 
promoter of genes under its regulation (Mendizabal et al. 2001; 
Stathopoulos and Cyert 1997). Inducible targets of Crz1 include CRZ1 
that encodes Crz1 (Matheos et al., 1997), RCN1 and RCN2 that encode 
positive and negative regulators of calcineurin (Mehta et al.,. 2009), 
PMC1, PMR1, and ENA1 that encode several P-type cation pumps 
responsible for efflux of Ca
2+
, Mn
2+
, Na
+
, and Li
+
, cell wall 
biosynthetic enzymes (FKS2) and many other genes that control other 
processes (Yoshimoto et al.,  2002). 
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2. Yeast as a model organism 
 
Yeasts are eukaryotic unicellular organisms belonging to the    kingdom 
Fungi. With an ovoid or spherical shape, the size of yeast cells typically 
measure 3–4 µm in diameter, although some yeasts can grow to 40 µm 
in size (Walker et al., 2002).  
Yeasts do not form a single taxonomic or phylogenetic group, indeed 
they are placed into two separate phyla: the Ascomycota (like 
Saccharomyces cerevisiae and Kluyveromyces lactis) and the 
Basidiomycota (Kurtzman, 1994). 
Some of the properties that make yeast suitable for biological studies 
include rapid growth, dispersed cells, the ease of mutant isolation, a 
well-defined genetic system, and most important, a highly versatile 
DNA transformation system. The useful physiological properties of 
yeasts have led to their use in the field of biotechnology; fermentation 
of sugars; moreover, yeast represents one of the most widely used 
model organisms for genetics and cell biology (Fig. 5). 
 
 
 
 
 
Fig. 5 Biotechnology fields involving yeast. (Tenreiro & Outeiro, 2010). 
 
An important theme of yeast biology is the use and study of 
homologous recombination, a process by which a broken piece of DNA 
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uses a homologous DNA template as a substrate for repair. Yeast use 
this process to ﬁx DNA damage, to switch mating types, and to 
segregate homologous chromosomes during meiosis. Researchers also 
use this pathway for genetic mapping and integrative transformation of 
DNA into speciﬁc locations of the genome. Much of what we have 
learned about cell and molecular biology has come from research on 
yeast. The genes and mechanisms involved in many cellular processes 
are highly conserved across eukaryotic taxa, so by studying the yeast 
we learn about the fundamental biology of all eukaryotes (Mell and 
Burgess, 2002). 
The yeast Saccharomyces cerevisiae is commonly known as baker’s 
yeast or brewer’s yeast and it is the most extensively characterized 
eukaryotic organism. Yeast cells divide about every 90 minutes under 
optimal laboratory conditions, through a process of budding in which 
smaller daughter cells pinch, or bud, off the mother cell. The common 
name “budding yeast” derives from this notable feature. In the haploid 
cell, S. cerevisieae genomic DNA is subdivided into 16 chromosomes  
and according to the SGD report of  February 2014 
(http://www.yeastgenome.org/), the “verified open reading frame 
(ORFs)” in the reference strain S288C stood at 5076 (Duina. et al., 
2014). 
Several features of yeast have been instrumental for our current 
understanding of conserved cellular mechanisms such as cell division, 
DNA replication, metabolism, protein folding and intracellular 
transport (Fields and Johnston, 2005). With a cell cycle that involves 
haploid and diploid forms, the study of lethal mutations in 
heterozygous diploids and recessive mutations in haploids is extremely 
simpliﬁed in yeast. Furthermore, classical genetic manipulations are 
facilitated by mating the haploid strains and sporulating diploid strains. 
Moreover, the high transformation efﬁciency of these cells and the 
presence of a very efﬁcient homologous recombination render 
relatively easy to insert, delete or mutate any genomic sequence up to 
the chromosome level (Sugiyama et al., 2009). Because of the 
advantages described above, S. cerevisiae was the ﬁrst eukaryotic 
organism to be fully sequenced in 1996 (Goffeau et al., 1996).  
At the moment, several biological resources exist for the yeast 
researchers. They include the yeast gene deletion strains (YGDS), 
where every protein-coding gene in the genome was deleted (Winzeler 
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et al., 1999); the green ﬂuorescent protein (GFP)-tagged collection of 
strains, where each gene was tagged with GFP (Huh et al., 2003); as 
well as a collection of plasmids for protein overexpression (Jones et al., 
2008). Additionally, high-throughput data obtained from functional 
genomics approaches, such as transcriptomics, proteomics and 
metabolomics are available. 
Notably, information about predicted orthologs in humans is also 
organized and available for each yeast gene (Tenreiro e Outeiro, 2010) 
 
 
 
2.1. Yeast as model of human disease 
 
Most of the basic cellular functions are conserved from yeast to humans 
as well as the diseases's key players are often evolutionary conserved. 
Indeed, 31% of the yeast genes have a mammalian homologue and an 
additional 30% of yeast genes show domain similarity (Botstein et al., 
1997). Consistently, about 30% of the genes known to be involved in 
human diseases may have a yeast orthologue (Botstein et al., 1997; 
Foury, 1997).  For these reasons, such as for its versatile genetic 
ﬂexibility, yeast has been increasingly used as a model and tool for 
biomedical research over the past one or two decades (Mager and 
Winderickx, 2005). 
Yeast models of human diseases enable identiﬁcation and 
characterization of key actors and possible therapeutic targets 
associated to considered disorders. Moreover, this simple organism is 
largely used to high-throughput genetic and small-molecule screens to 
find possible pharmacological drugs. 
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Fig. 6 The uses of yeast as model for human diseases (Voisset et al., 2014). 
 
 
 
In order to create a proper yeast model for a given human pathology, it 
is ﬁrst necessary to get a phenotype, which is relevant close to the 
known pathological mechanism and easy to follow using classical yeast 
tools.  
 
 
 
2.1.1. Yeast modelling for mitochondrial disorders 
 
In the simplest cases, where a functional homolog of the affected 
protein in human exists in yeast, the mutated forms of the human 
mutant proteins can be expressed directly in yeast strains in which the 
corresponding yeast gene has been deleted. Hence, the use of yeast to 
determine the functionality of mutated alleles of genes involved in 
genetic diseases has been largely exploited in the ﬁeld of mitochondrial 
diseases. Indeed, much of our current understanding of mitochondrial 
function and dysfunction comes from studies in the baker’s yeast 
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Saccharomyces cerevisiae. Because of its good fermenting capacity, S. 
cerevisiae can survive mutations that inactivate oxidative 
phosphorylation, it has the ability to tolerate the complete loss of 
mitochondrial DNA (a property referred to as ‘petite-positivity’), and is 
amenable to mitochondrial and nuclear genome manipulation (Lasserre 
et al., 2015).  
For example, yeast model was used to investigate the effects of 
mutations in the mitochondrally- encoded gene ATP6. Mutations in this 
gene causes a devastating mitochondrial disease, the NARP 
(Neuropathy, Ataxia, Retinitis Pigmentosa) syndrome (Couplan et al., 
2011). The expression of a mutated human form of ATP6 (T9176G) in 
yeast severely was found to impede the incorporation of encoding 
subunit 6 in the yeast ATP synthase (Kucharczyk et al., 2010), and 
evidences for similar defects have been reported in skin fibroblasts 
from patients carrying this mutation (Carrozzo et al., 2001). Another 
approach introduced the identiﬁed mutations of human ATP6 gene in 
the yeast homologue to identify genes and drugs that suppress their 
respiratory growth phenotype (Couplan et al., 2011). These yeast-
NARP models were further validated when these drugs were shown to 
also suppress the respiratory growth of cells derived from NARP 
patients. 
 
 
 
2.1.2. Yeast gene as prototype 
 
In the absence of a functional ortholog, yeast models can still be 
created by using yeast genes as “prototypes”. This approach has been 
performed for prion-related diseases. Indeed, although they present no 
homology with the mammalian prion PrP, yeast prions themselves were 
used as models for PrP, based on the initial assumption that prion-
controlling mechanisms may be conserved throughout evolution. 
Moreover, like their mammalian counterpart, yeast prions form 
autocatalytic amyloid ﬁbers, which are partially resistant to proteinase 
K. A yeast assay was therefore developed to isolate antiprion 
compounds based on their activity against two unrelated yeast prions 
(Tribouillard et al., 2006). The isolated active molecules then turned 
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out to be active against mammalian prion both in cell-based assays and 
in vivo in a mouse model for prion diseases (Oumata et al., 2013). 
Importantly, this study constitutes the ﬁrst functional evidence that at 
least some cellular mechanisms involved in prion propagation are 
conserved from yeast to human. 
 
 
 
2.1.3. Yeast model for nuerodegenerative disorders 
 
When neither functional orthologue nor prototype gene exists in yeast, 
human disease models can be created by heterologous expression of the 
human mutated protein in yeast. This type of approach has been largely 
used in the ﬁeld of neurodegenerative diseases like Huntington’s 
(Giorgini et al., 2005; Zhang et al., 2005), Parkinson’s (Outeiro and 
Lindquist, 2003) and Alzheimer’s disease (Fig. 7).  
 
 
 
 
Fig. 7 Yeast as model of neurodegenerative disease (Fruhmann et al., 2016). 
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Although the human proteins involved in these diseases have no 
functional homolog in yeast, upon expression in this organism they 
form protein aggregative ﬁbers, the hallmark of these disorders, that 
can even, at least in some cases and/or situations, be toxic for yeast 
cells, thereby mimicking the situation observed in human neuronal cells 
(Outeiro  and Lindquist , 2003). 
For the Huntington’s disease, a mutant form of the ﬁrst exon of 
Huntingtin containing the expanded polyglutamine domain (103Q 
instead of 25Q in the wild type allele) was expressed in budding yeast, 
where the encoding protein aggregated and was toxic as in patients' 
neuronal cells (Giorgini et al., 2005). Moreover, using a collection of 
haploid strains deleted for every single non-essential yeast genes was 
found that aggregates of Htt103Q were not toxic in some yeast mutants, 
like in the bna4 mutant. This discovery suggested that the Bna4 gene, 
which encodes kynurenine 3-monooxygenase (KMO), an enzyme of 
the kynurenine pathway of tryptophan degradation highly conserved 
from yeast to humans, is a putative therapeutic target for the treatment 
of Huntington’s disease. This hypothesis was later on 
pharmacologically validated using chemical inhibitors of KMO in 
animal models for both Huntington’s and Alzheimer’s diseases 
(Zwilling et al., 2011). 
Mutations in -synuclein, causing Parkinson’s disease (PD), were also 
expressed successfully in yeast, where mutated protein accumulated 
into cytoplasmic inclusions like in human neurons (Outeiro and 
Lindquist, 2003). 
Furthermore, Cooper and co-workers demonstrated that in yeast -
synuclein aggregates impair vesicle transport from the ER to the Golgi. 
In the same study, a genome-wide overexpression screen identiﬁed the 
small GTPase Ypt1 as a modiﬁer of -synuclein toxicity. 
Overexpression of Ypt1p was sufﬁcient to prevent -synuclein toxicity, 
by enabling forward trafﬁcking from the ER to the Golgi. This 
observation was further extended to Drosophila and C. elegans models 
of PD, as well as in rat midbrain primary neurons, where Rab1—the 
functionally ortholog of Ypt1p— suppressed dopaminergic neuron loss 
that characterized PD patient (Cooper et al., 2006). 
Finally, yeast is still a powerful model to study Alzheimer’s disease 
(AD), characterized by the presence in neurons of intracellular 
neurofibrillary tangles (NFT) of Tau protein and extracellular plaques 
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of β-amyloid (Aβ) (Guo and Lee, 2014;Lee et al., 2001). Among the 
yeast studies of Alzheimer, one in 2011 identiﬁed different modiﬁers of 
-amyloid toxicity that are conserved from yeast to humans (Treusch et 
al., 2011). One of these modifiers was YAP1802, a suppressor of -
amyloid proteotoxicity that is involved in clathrin-mediated 
endocytosis. Its human homolog PICALM is also involved in 
endocytosis and has been validated as a high-risk factor for AD. 
YAP1802 prevents -amyloid toxicity in yeast and PICALM prevents 
-amyloid toxicity in rat cortical neurons. Notably, this study identiﬁes 
a causal gene for susceptibility to AD and proposes defective 
endocytosis as a contributing factor in AD pathology, with a possible 
role for PICALM. 
Therefore, in all of these models, the basic idea is always obtaining a 
yeast phenotype that is relevant for the considered disorders which then 
offers the possibility to search for modiﬁers that either suppress or 
exacerbate a given phenotype. Modiﬁers can include drugs, genes or 
any other biological or chemical moiety.  
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3. The yeast model of Hailey Hailey disease 
 
3.1. Hailey Hailey disease 
 
Hailey-Hailey disease (HHD), also called benign familial pemphigus, is 
an autosomal dominant blistering skin disorder  manifesting in the 3
rd
 
to 4
th
 decades of life and with an incidence of 1:50000 (Vasudevan et 
al., 2015). The name comes from the first described case by two 
brothers William Howard Hailey and Hugh Edward Hailey, in 1939. 
The two siblings had recurrent bullae and erosion on their neck regions, 
and they referred to the pathology as chronic erosive bullous 
dermatosis of flexures (Engin et al., 2015). 
The genetics and pathophysiology of HHD have been linked to 
mutations in the ATP2C1 gene (Sudbrak et al., 2000; Hu et al., 2000).  
The gene, located on the long arm of chromosome 3; 3q21-q24 region, 
encodes the human secretory pathway Ca
2+
/Mn
2+
 ATPase, hSPCA1 
(Wuytack et al., 2002). 
This pump is ubiquitously expressed in human tissues but with the 
greatest abundance in keratinocytes (Hu et al., 2000). Although, 
hSPCA1 is mostly localized to the Golgi apparatus, it detectably 
contributes to filling up ER Ca
2+
 stores in certain cell types and has 
been shown to exert effects on both Golgi and ER functions. 
The contribution of hSPCA1 to the total Ca
2+
 uptake of the Golgi varies 
among different cell types from 15% to 50%; however, in 
keratinocytes, the role of SPCA1 is even more significant (Missiaen et 
al., 2004). This in part may explain why only the skin is affected in 
HHD, although the exact reason for this phenomenon is currently not 
well understood. One hypothesis is maybe because calcium has 
important regulator function in keratinocyte proliferation and 
differentiation (Yuspa et al., 1988).  
More than 100 different mutations in ATP2C1 have been reported in 
HHD. Among these 20% are nonsense mutations, 19% are splice site 
mutations, 30% are frameshift mutations leading to premature 
termination codons (PTC), 28% are missense mutations, and ∼3% are 
in-frame deletions or insertions (Kellermayer, 2005). 
The high number of PTC mutations suggests the haploinsufficiency as 
the prevalent mechanism for the dominant inheritance of HHD. Studies 
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on missense mutations shown that while mutant ATP2C1 mRNA levels 
are normal, the level of the defective protein is lower than that of the 
wild type despite correct targeting to the Golgi, supporting the thesis of 
haploinsufficiency.  
Interestingly, the expression of ATP2C1 was downregulated in cells 
derived from lesional skin areas of HHD patients but not in 
keratinocytes originating from unaffected skin areas of the same patient 
(Cialfi et al., 2010). 
The lack of ATP2C1 impairs keratinocytes ability to store Ca
2+
 
normally and this leads to the loss of cell-to-cell adhesion (called 
acantholysis) among the cells of the suprabasal layer of epidermis 
probably due to a retraction of keratin intermediate filaments from the 
desmosomal plaques (Dobson-Stone et al., 2002). 
In the healthy epidermis, a Ca
2+
 gradient is present with lowest calcium 
levels in the basal layer and highest in the granular layer of the skin 
both intra and extracellularly. This gradient appears to be a key element 
for the keratinocyte differentiation, in which the calcium sensing 
receptor (CaR) is an important player (Elias et al., 2002; Tu et al., 
2001). 
In HHD epidermis, both in the lesional and intact skin, this calcium 
gradient is absent, likely due to the inability of HHD keratinocytes to 
accumulate calcium properly upon increasing extracellular levels of 
Ca
2+
, that occurs for example after noxious stimuli. While total calcium 
levels are significantly decreased in the granular layer of the HHD, the 
basal and suprabasal layers contain similar amounts of calcium as the 
healthy skin (Hu et al., 2000). These observations support the idea that 
the primary defect in HHD skin is the decreased amount of total 
calcium in the granular layer, although the suprabasal keratinocytes 
suffer from desmosomal disruption (Fig. 8). HHD keratinocytes have 
also normal amounts of desmosomal proteins that can bind other 
proteins with the same efficiency as seen in normal epidermal cells; 
moreover, desmosome formation and response to UVB irradiation are 
similar between HHD and normal keratinocyte cultures. These 
observations indicate that the whole changed environment of the 
epidermis is required for the alteration in the HHD keratinocyte 
desmosome assembly. 
In addition, altered Ca
2+
 homeostasis in HHD keratinocytes seems to 
induce an early defect in differentiation process due to a reduced 
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production of involucrin, a protein that makes up the cornified envelope 
of keratinocytes and that is expressed in response to increased 
intracellular Ca
2+
 concentrations  (Aberg et al., 2007).  
Some specific mRNAs and oxidative stress may have roles in the 
pathogenesis of HHD. Indeed oxidative stress that characterized HHD 
keratinocytes leads an increased expression of the miR-125b. In 
lesional-derived keratinocytes of HHD patients, this mRNA seems to 
be involved in the down-modulation of notch1 and p63, two key factors 
in the keratinocyte proliferation and differentiation (Cialfi et al., 2010; 
Manca et al., 2011). 
 
 
 
 
 
Fig. 8 Suprabasal acantholysis in HHD keratinocytes due to the altered calcium 
homeostasis (Elias et al., 2002) 
 
 
 
27 
 
As a result, keratinocytes do not stick tightly to one another, so the 
epidermis becomes fragile and less resistant to minor trauma. Because 
the skin is easily damaged, it develops raw, blistered areas, particularly 
in skin folds where there is wetness and friction (Fig. 9). Indeed the 
areas mostly affected are neck, axillae and groins.  
 
 
 
 
 
Fig. 9 (A) Erythematous plaque with multiple fissures on axillary region (Engin et al., 
2015). (B) Suprabasalar and intraepidermal keratinocyte acantholysis (Graham et al., 
2016). 
 
 
 
The disease has a fluctuating course with remissions and exacerbations 
and in rare instances, the rash may become generalized (Chave and 
Milligan, 2002); rarely, skin lesions may develop into squamous cell 
carcinomas (Chun et al., 1988; Cockayne et al., 2000) or melanomas 
(Mohr et al., 2011). 
Important factors that can trigger the manifestation of the pathology 
are: menstruation, pregnancy, skin infections, physical trauma, 
excessive sweating and exposure to ultraviolet radiation. 
At present, there is no reported cure for HHD and current treatments 
are not particularly effective in all patients. The treatment is primarily 
aimed at symptomatic relief.  Since superinfection with bacteria, fungi, 
and viruses plays an important role in exacerbations and persistence of 
lesions, topical antibiotics, antifungal and antiviral agents are 
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commonly used in the HHD lesion treatments. Moreover systemic, 
topical, and intralesional corticosteroids have been found to be useful in 
the management of HHD in many cases (James et al., 2006; D’Errico et 
al., 2012) 
Other drugs that have also proved to be effective in some cases are 
cyclosporine, retinoids, botulinum toxin A, and dapsone (Bagherani 
and Smoller, 2016; Engin et al., 2015). Particularly, the botulinum 
toxin A seems to be effective by decreasing sweat and subsequent 
microorganism colonization of lesion (Bessa et al., 2010). Meanwhile, 
ablative lasers give better results with the recalcitrant plaques of HHD 
patients (Ortiz and Zachary, 2011).  
 
 
 
3.2. Yeast as model of HHD 
 
As described before, few is known about the molecular factors and 
pathways involved in HHD pathogenesis; moreover, therapies are not 
available. Moreover, a mouse model does not exist. In fact, meanwhile 
null mutant Spca1−/− embryos did not survive to the gestation, 
heterozygous mice for ATP2C1 do not develop the typical vesicular 
lesions of human patients.  Indeed, they have only an increased 
incidence of squamous cell tumors (Okunade et al., 2007). 
As mentioned above, in the last 10-20 years the yeast, in particular S. 
cerevisiae, has become an effective and simple model system to 
understand the molecular players associated to a given pathology.  
This is still true in the study of Hailey-Hailey disease. Both the budding 
yeasts S. cerevisiae and Kluyveromyces lactis (K. lactis) express the 
orthologue gene of ATP2C1, called PMR1 (plasma membrane ATPase 
related) (Uccelletti et al., 1999; Rudolph et al., 1989). Expression of the 
human ATP2C1 in yeast fully rescues the yeast pmr1 hypersensitivity 
to Ca
2+
 chelators and Mn
2+
 toxicity (Ton et al, 2002). Although 
ATP2C1 shares only 49% amino acid sequence identity with Pmr1, the 
transmembrane domains known to be important for the ion transport 
are almost completely conserved. This observations validated the use of 
yeast PMR1 gene to study some aspects of ATP2C1 function, to 
determinate the functionality of mutated alleles of ATP2C1 found in 
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HHD patients and then to explore the pathophysiology and potential 
therapy of this genodermatosis (Mauro, 2004;  Ton and  Rao, 2004). 
Pmr1p is responsible for maintaining Ca
2+
/Mn
2+
 homeostasis in both 
Golgi apparatus and ER. Although it is not essential, cells deprived of 
Pmr1p display pleiotropic phenotypes, some of them resembling those 
reported in HHD keratinocytes, including alterations in Ca
2+
 
homeostasis, mitochondrial alterations and ROS accumulation  (Hu et 
al. 2000; Uccelletti et al., 2005).  
Moreover, as a result of Ca
2+
 and Mn
2+ deﬁciency within the ER and 
Golgi, the pmr1Δ mutant is defective in protein sorting and processing 
through the secretory pathway (Durr et al., 1998; Ramos-Castañeda et 
al., 2005). The alterations in protein processing cause an accumulation 
of chitin in the pmr1∆ mutant. As a result the mutant cells become 
hypersensitive to the chitin binding stilbene ﬂuorescent brightener 
calcoﬂuor white (CFW). This phenotype of pmr1 can be used to 
screen drugs that could have therapeutic effects on HHD. For example 
Voisset et al., used this CFW-phenotype of the pmr1∆ mutant to screen 
two different chemical libraries, looking for suppressors of the CFW-
sensitivity (Voisset et al., 2014). However, the molecular mechanisms 
of these compounds are unknown and they need to be validated on 
human cell-based models of Hailey–Hailey disease. 
Furthermore, studies in S. cerevisiae elucidate the action mechanism of 
tacrolimus (FK506) and cyclosporine, two immunosuppressors used in 
some case of recalcitrant Hailey–Hailey (Rabeni and Cunningham, 
2002; Varada et al., 2015). These two compounds are calcineurin 
inhibitors and although their major mechanism of action is presumably 
the suppression of lymphocyte activation, a non immunomodulatory 
mechanism has also been proposed. Studies on the effects of 
calcineurin inhibition in S. cerevisiae pmr1 mutants showed that 
cyclosporine induced tolerance to high extracellular Ca
2+
 environment 
through vacuolar Ca
2+
/H
+
 exchanger activity of Vcx1 (Szigeti and 
Kellermayer, 2004). Moreover, FK506 (tacrolimus) has been found to 
augment Vcx1 function in pmc1 yeast under Ca2+ stress (Cunningham 
and Fink, 1996). Although calcineurin has been shown to be 
functionally active in human HHD keratinocytes (Al Daraji et al, 
2002), the observations in yeast suggest that calcineurin inhibitors such 
as tacrolimus and cyclosporine may be beneﬁcial in the treatment of 
Hailey–Hailey disease by decreasing Ca2+ stress in epidermal cells. 
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Other studies showed that yeast is a powerful model organism for 
Hailey Hailey disease. Indeed, in the yeast Kluyveromyces lactis the 
loss of PMR1 provokes an increased ROS production compared to wild 
type cells (Uccelletti et al., 2005),as well as keratinocytes derived from 
lesional skin show an increased ROS levels compared to non lesional-
derived ones of the same HHD patients (Cialfi et al., 2010) 
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4. The yeast Kluyveromyces lactis  
 
Kluyveromyces lactis is both scientifically and biotechnologically one 
of the most relevant non-Saccharomyces yeasts. Its biotechnological 
significance builds on its history of safe use in the food industry and its 
well-known ability to produce enzymes like lactase and bovine 
chymosin on industrial scale (Faraco et al., 2008; van Ooyen et al., 
2006). 
This microorganism grows in optimal temperature at 25°C to 40°C and 
the cells have oval form and typically measure 3–4 µm in diameter 
(Fig. 10). 
 
 
 
 
 
Fig. 10 Kluyveromyces lactis cells. 
 
 
 
Its genome is divided up into 6 chromosomes ranging in size between 1 
Mbp and >3 Mbp. 
Because K. lactis can ferment lactose it is mainly used in the dairy 
industry. Some of the most important applications include the industrial 
production of native β-galactosidase and recombinant milk clotting 
enzyme bovine, chymosin. This protein was the first heterologous 
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enzyme originating from a higher eukaryote that was produced at low 
cost in a microorganism, and the process developed for its industrial-
scale production was widely recognized as a major biotechnological 
achievement (van den Berg et al., 1990).  
Moreover, the enzyme β-galactosidase is used to produce lactose-free 
dairy products and prebiotic galacto-oligosaccharides (GOS) (Alves 
Macedo et al., 2003; Guerrero et al., 2015).  
Given its successful applications in the dairy industry, K. lactis was 
later introduced as a host for the large-scale production of heterologous 
proteins in the pharmaceutical industry. One example is the production 
of human interleukin-1β, which is used to treat autoimmune disorders 
(Fleer et al., 1991; Maedler et al., 2009).  
K. lactis has a number of advantages over other yeast expression 
systems, including easy genetic manipulation, the ability to use both 
integrative and episomal expression vectors, and the availablility of a 
fully sequenced genome (Dujon, 2004). Growth of K. lactis cells can be 
performed in standard yeast medium and does not require the 
explosion-proof fermentation equipment necessary for large-scale 
growth of methylotrophic yeasts such as Pichia pastoris. In addition, 
enzymes from K. lactis have GRAS (Generally Regarded As Safe) 
FDA status, permitting their use in various food and feed applications 
(van Ooyen et al., 2006). 
K. lactis, like S. cerevisiae, also facilitates the investigation of basic 
cellular processes. The existence of different protein isoforms makes 
the analysis of in vivo protein functions or complementation assays 
with human proteins challenging (Spohner et al., 2016). Unlike S. 
cerevisiae, K. lactis has not undergone whole genome duplication and 
most enzymes and other proteins occur as single isoform. K. lactis is 
therefore a more suitable model than other yeasts for the investigation 
of human diseases and cellular defence mechanisms (Bharadwaj et al., 
2010; González Siso and Cerdán, 2012). 
Finally, the regulatory circuits of K. lactis responses to oxygen 
limitations have stronger resemblance in humans, compared to S. 
cerevisiae redox metabolism. Indeed, K. lactis is characterized, 
opposite to S. cerevisiae, by a higher glucose flow through the pentose 
phosphate pathway (PPP) than through glycolysis. Thus, K. lactis is 
proposed as a respiratory eukaryote model, complementary to the 
fermentative S. cerevisiae, for the study of the pathways of hypoxia-
33 
 
induced oxidative stress, which are related to human diseases such as 
Alzheimer’s and Parkinson’s (Gonzalez Siso and Cerdan, 2012). 
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AIM OF THE PROJECT 
 
Over the past one or two decades, yeast has been increasingly used as a 
model and tool for biomedical research (Mager and Winderickx, 2005; 
Perocchi et al., 2008). The reasons lie in the unique characteristics of 
this eukaryotic unicellular organism. Indeed, it is experimentally 
tractable with a rapid doubling time and it grows in very simple culture 
conditions; yeast is thus a eukaryote easy to handle as a prokaryote.  
In addition, numerous powerful tools are available when working with 
this simple model, like classical genetics, cell biology, biochemistry 
and molecular genetics. Indeed the genome of budding yeast S. 
cerevisiae was the first eukaryotic genome to be sequenced (Goffeau et 
al., 1996) and it can be modified at will at the nucleotide level. 
Therefore, all its essential genes have been identified.  
Furthermore, a huge number of systematic approaches (transcriptomic, 
proteomic, locabolomic, interactomic, metabolomic, etc.) have been 
carried out in yeast and their results are freely available. Thanks to the 
richness of this molecular toolbox, yeast has long been used as a 
powerful model system for basic research on the most fundamental 
cellular mechanisms, like mitochondrial functions, transcription, 
translation, DNA replication or secretion. 
Most of the basic cellular functions are conserved from yeast to humans 
as well as the diseases's key players are often evolutionary conserved. 
Indeed, about 30% of the genes known to be involved in human 
diseases may have a yeast orthologue (Botstein et al., 1997; Foury, 
1997).  For these reasons, such as for its versatile genetic ﬂexibility, 
yeast is used as a model and tool to investigate the molecular 
mechanism and players involved in human disease (Mager and 
Winderickx, 2005). 
Besides, this simple organism is largely used to high-throughput 
genetic and small-molecule screens to find possible pharmacological 
drugs. 
 
Hailey–Hailey disease (HHD), also known as familial benign chronic 
pemphigus, is a rare, chronic and recurrent blistering disorder. It is 
histologically characterized by the lost of contact among the 
keratinocytes of suprabasal layer of skin (acantholysis). The genetics 
and pathophysiology of HHD have been linked to mutations in the 
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ATP2C1 gene encoding for hSPCA1, a Ca
2+
/Mn
2+
-ATPase pump (Hu 
et al, 2000).  
At the moment, few is known about the molecular players involved in 
HHD pathogenesis.  
Moreover, mouse does not represent a good model for this disorder. In 
fact, whereas the Spca1−/− embryos do not survive to the gestation, in 
the heterozygous mice for ATP2C1 the typical vesicular lesions are 
absent.  Instead, they have an increased incidence of squamous cell 
tumors (Okunade et al., 2007) that are very rare in the HHD patients. 
In yeast, PMR1 is the ortologue gene of ATP2C1. Expressing the 
human ATP2C1 in yeast S. cerevisiae fully rescues the yeast pmr1 
hypersensitivity to Ca
2+
 chelators and Mn
2+
 toxicity (Ton et al, 2002) 
and although hSPCA1 shares only 49% amino acid sequence identity 
with Pmr1, the transmembrane domains known to be important for 
transport are almost completely conserved. 
Furthermore, in the budding yeast Kluyveromyces lactis the loss of 
PMR1 provokes an increased ROS production compared to wild type 
cells (Uccelletti et al., 2005), similar to the HHD keratinocytes derived 
from lesional skin that showed a higher levels of ROS with respect to 
the no lesional-derived ones of the same HHD patients (Cialfi et al. 
2010). 
This and other observations indicate that yeast can be a useful simple 
model to study the molecular mechanism involved in the HHD 
pathogenesis.   
For this reason, we use the genetic tractable yeast K. lactis to analyze 
the relationship between calcium and ROS production in 
ATP2C1/PMR1- deleted cells. To this aim, we will perform a genetic 
screening to identify molecular player able to alleviate the oxidative 
stress and/or the calcium alterations that characterize pmr1 cells. 
 
Currently a specific cure for HHD patients is absent; indeed, primary 
treatments consist of topical antibiotics and antifungal to fight the 
infections that plays an important role in exacerbations and persistence 
of lesions. Also topical and intralesional corticosteroids have been used 
in the management of HHD in many cases to reduce the inflammation 
of the skin lesions (Voisset et al., 2014). 
Thus, to extend our knowledge on compounds that improve the 
condition of HHD patients, in parallel with the genetic screening we 
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will perform a pharmacological screening. We will take advantage of 
the 131 FDA-approved natural compounds to analyze their ability to 
suppress the pmr1 phenotypes. In the initial screening system we will 
evaluate if the drugs are able to recover the cell wall defects of our 
mutant. 
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RESULTS 
 
1. Glutathione S-transferase Theta-subunit and Hailey-
Hailey Disease: from yeast to human keratinocytes 
 
1.1. Glutathione S-transferase rescues the oxidative stress 
of Klpmr1-deleted cells  
 
In a previous work, we demonstrated that the pmr1 mutant is 
characterized by altered mitochondrial morphology associated with 
increased accumulation of reactive oxygen species (ROS) (Uccelletti et 
al., 2005). In order to investigate the possible molecular interactions of 
Pmr1, we performed a genetic screening to identify multicopy 
suppressors able to relieve the growth sensitivity to hydrogen peroxide 
(H2O2) of cells lacking the Ca
2+
-ATPase activity. To this aim, we 
transformed Klpmr1 cells with a cDNA library derived from MDCK 
cells (Guillen et al., 1998) and we selected the positive clones that were 
able to growth in the presence of H2O2. The screening allowed the 
identification of the Glutathione S-Transferase ϴ-subunit (GST), an 
important detoxifying enzyme, as the suppressor able to completely 
rescue the growth defects of pmr1Δ cells in the presence of the stressor 
molecule (Fig1A). In figure 1B, it is shown the alignment of the amino 
acid sequence of K. lactis with related GSTs from S. cerevisiae and 
higher eukaryotes, e.g. human and Canis lupus familiaris, highlighting 
several regions with high degree of similarity. Based on this, a 
transcription analysis of the yeast gene of Glutathione S-transferase 
(GTT1) was thus performed. As shown in fig. 1C, a reduction in GTT1 
transcript was observed in the Klpmr1 mutant strain in comparison 
with its wild type counterpart 
38 
 
 
 
 
Fig. 1 (A) The genetic screening with the MDCK cDNA library allowed the 
identification of GST as a suppressor of the pmr1 sensitivity to H2O2. (B) Amino 
acid alignment of the K. lactis, S. cerevisiae, Canis lupus familiaris and Homo 
sapiens Glutathione S-transferase protein. Identical amino acids are indicated with a 
star (*), meanwhile conservative or semi-conservative substitutions are showed with a 
colon (:) or period (.), respectively. (C) Transcript levels of K. lactis  Glutathione S-
transferase GTT1. (D) ROS levels in wild type (black bar), pmr1 (grey bar) and in 
transformed (white bar) strains. 
(B) 
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To confirm the relief of oxidative stress by GST overexpression, we 
measured the ROS production of our strains using the cytofluorimetric 
analysis. As shown in fig. 1D, effectively, ROS accumulation was 
completely suppressed by enhancing Glutathione S-Transferase 
transcription in the mutant cells.  
Next we also evaluated the transcriptional profile of different key 
enzymes involved in oxidative stress detoxification (Fig. 2). While no 
changes were observed for the cytosolic (SOD1) and mitochondrial 
(SOD2) superoxide dismutase genes,  mRNA levels of both cytosolic 
(CTT1) and peroxisomal (CTA1) catalases were high in the Klpmr1 
genetic background (Fig. 2). However, the increase in mRNA levels 
was completely abolished by GST over-expression in the case of CTT1 
gene (Fig. 2).  
 
 
 
 
Fig. 2 Transcriptional level of superoxide desmutases and catalases in WT, PMR1-
deleted cells and Klpmr1+ pGST 
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1.2. The mitochondrial dysfunction of mutant cells is 
recovered  by GST overexpression 
 
Since mitochondrial alterations are often associated with ROS 
accumulation, we wondered if GST may relieve the mitochondrial 
dysfunction that characterized the KlPMR1-deleted cells (Uccelletti et 
al., 2005). To this aim, K. lactis cells were stained with DASPMI, a 
fluorescent probe that is taken up by mitochondria as a function of 
membrane electrochemical potential. The overexpression of the 
mammalian GST in the mutant cells rescued the mitochondrial 
functionality with a full recovery of the wild type-like tubular 
mitochondrial network; meanwhile in the cells lacking of PMR1 we 
observed the presence of dots, indicating an alteration in the 
mitochondrial activity (Fig. 3). 
 
 
Fig. 3 Fluorescence micrographs of DASPMI-stained cells. All pictures were taken at 
the X100 magnification; scale bar 2 m. 
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1.3. GST is able to alleviate the calcium alteration of 
KlPMR1 deleted cells 
 
Previously in our laboratory it was found that the loss of the Golgi 
Ca
2+
-ATPase in K. lactis cells determined calcium-related phenotypes, 
including high levels of cytosolic calcium ([Ca
2+
]cyt) (Uccelletti et al., 
2005). Thus we investigated if the overexpression of mammalian GST 
was able to affect the calcium alterations of pmr1 cells. By 
cytofluorimetric analysis, we observed that Glutathione S-Transferase 
only partially suppressed the increased cytosolic calcium levels of the 
mutant strain (Fig. 4 A). Furthermore, the survival of cells challenged 
with EGTA was assessed and the high sensitivity of the pmr1 strain 
was re-established to values identical to the wild type by GST 
overexpression (Fig. 4B).  
 
 
Fig. 4 (A) Intracellular calcium content measured by using FLUO-3AM probe and 
expressed as fluorescence relative to wild type strain. (B) Cell survival of the 
indicated yeast strains challenged with the calcium chelator EGTA for 6h. After 
incubation, cells were diluted and plated onto YPD plates. CFU were counted after 
growth at 28°C for 2 d and results were expressed as cell survival percentage in 
comparison to untreated controls, set as 100%. 
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1.4. The cell wall alterations in Klpmr1 cells are 
recovered by GST overespression 
 
We previously reported that K. lactis strain deleted for PMR1 gene had 
a thicker and disorganized cell wall (Uccelletti et al., 2005). We took 
advantage of the Calcofluor white (CFW), a fluorescent dye that binds 
primarily to chitin, one of the cell wall components. To analyze the 
effect of GST overexpression on cell wall structure, the CFW 
fluorescence assay was performed.  After CFW staining, wild type cells 
showed the characteristic chitin deposition, localized only at the bud 
scars meanwhile the mutant strain exhibited an abnormal distribution of 
chitin across the entire cell surface. The overexpression of mammalian 
GTS completely suppressed the cell wall alterations of mutant cells. 
Indeed, like wild type cells, in the transformant strain the fluorescence 
is mainly localized at the division septum (Fig. 5).  
 
 
 
Fig. 5 Chitin distribution was analyzed by calcofluor white staining for the indicated 
strains grown to late exponential phase. All the pictures were taken at the same 
magnification; scale bar 2 m. 
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1.5. GST effects on calcium homeostasis, cell wall and 
oxidative stress are mediated by calcineurin 
 
Calcineurin (CN) is a Ca
2+
/calmodulin-dependent serine/threonine 
protein phosphatase that is highly conserved in eukaryotes from yeast 
to mammals. It plays a crucial role in the Ca
2+
 signaling pathway 
(Miyakawa and Mizunuma, 2007) and its activation is necessary to 
maintain growth under different cellular stresses. In yeast, calcineurin 
is a heterodimer composed by a catalytic subunit (Cna1) and a Ca
2+
-
binding regulatory B subunit (Cnb1), and the association between the 
two subunits is necessary for phosphatase activity. Interestingly, the 
two-subunit structure is well conserved from yeast to human.  
Thus, we explored if the phenotypes observed in pmr1 strain may be 
associated with defects in the calcineurin pathway. We analyzed the 
transcriptional levels of CNA1 in wild type and mutant cells, and found 
no significant differences in CNA1 transcriptional levels (Fig. 6A). 
However, the activation of calcineurin was evaluated by analyzing the 
expression of one of its target genes, PMC1. This gene encodes a 
vacuolar Ca
2+
 pump that works to sequester calcium inside the vacuole, 
the main calcium store of yeast cells. As shown in Fig. 6B, in pmr1 
strain we found a high amount of PMC1 transcript compared to wild 
type levels, indicative of CN activation. In fact, the increased levels of 
PMC1 transcript were not observed when CNB1 gene was deleted in 
those cells (Fig. 6B). These results strongly suggest that CN regulates 
the expression of PMC1 gene in response to increased Ca
2+
 in the 
mutant cells. According to the high Ca
2+
 levels in mutant strain, the 
GST overexpression in pmr1 cells induced a partial reduction of 
PMC1 transcript (Fig. 6B). Instead, no significant changes were 
observed for the VCX1 gene  encoding the vacuolar Ca
2+
 exchanger 
(Fig. 6C)  
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Fig. 6 Gene expression analysis of the regolaroty subunit of calcineurin CNA1(A), the  
vacuolar Ca
2+
 pump PMC1 (B) and the vacuolar  Ca
2+
/H
+
  exchenger VCX1(C). 
 
 
 
Additionally, the calcium homeostasis defects, as well as the oxidative 
stress, observed in the mutant cells, were exacerbated in the 
pmr1cnb1 double mutant strain, as indicated by the higher 
sensitivity of this strain to the EGTA and H2O2 (Fig. 7A-B).  
Moreover, calcineurin is a key element in the Cell Wall Integrity (CWI) 
pathway that is mainly activated by cell wall stress (Fuchs and 
Mylonakis, 2009).  Since our mutant presented alterations in cell wall 
organization, we analyzed the GST effect on the cell wall in 
pmr1cnb1 double mutant strain. Our data revealed the inability of 
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GST to suppress also the cell wall morphology in the double mutant. 
(Fig. 7C). 
 
 
.  
Fig. 7 (A) Cell survival of the pmr1cnb1strain, over-expressing or not GST,. 
challenged with the calcium chelator EGTA for 6h. (B) Sensitivity to hydrogen 
peroxide of the double mutant. (C) Cell wall analysis of the indicated strains through 
calcofluor staining of chitin. Scale bar 2 m.  
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1.6. GST recovers the mitochondria functionality in a 
calcineurin-independent manner 
 
Next we analyzed whether mammalian Glutathione S-Transferase was 
able to restore the mitochondria functionality when CNB1 gene is 
inactivated in PMR1-deleted cells. Surprisingly, however, we found 
that GST overexpression was sufficient to restore mitochondrial 
functionality in the double mutants (Fig. 8), indicating in this case a 
mechanism of action for GST calcineurin independent.  
 
 
 
Fig. 8 DASPMI staining of the double mutant pmr1cnb1expressing or not the 
mammalian GST. All pictures were taken at the same magnification; scale bar 2 m. 
 
 
 
 
 
47 
 
1.7. Alcohol dehydrogenase 3 recovers the mitochondria 
alterations of pmr1 cells 
 
Since GST was able to suppress the mitochondrial defects of pmr1 
cells calcineurin-independently, we tried to identify the possible 
mediator that allowed the mammalian protein to recover this 
phenotype.  
We thus investigated the role of alcohol dehydrogenases (Adhs) that 
have a central role in the oxidative metabolism. These enzymes 
catalyze the production and assimilation of alcohols and they are 
ubiquitously distributed in most organisms (Lertwattanasakul et al., 
2015). In K. lactis there are four isoforms of Adhs: Adh1 and Adh2 are 
cytosolic enzymes, meanwhile Adh3 and Adh4 are mitochondrial 
proteins (Saliola et al., 1990; Saliola et al., 1991). We investigated the 
activity of the KlAdhs in our strains; we found that, in the pmr1 cell 
over-expressing GST, the activity of the Adh3 was higher when 
compared to wild type and mutant cells (Fig.9).  
 
 
 
Fig. 9 Electrophoretic analysis of ADHs. 10 g of protein, were electrophoresed on 
non-denaturing polyacrylamide gels and the ADH isozymes were revealed as bands 
by staining the gel for the enzyme activity. G6PDH activity was used as control. 
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KlAdh3 is responsible for maintaining the mitochondrial redox balance 
by contributing to the reoxidation of cytosolic NAD(P)H (Bozzi et al., 
1997). 
Thus, we decided to investigate directly the role of KlADH3 in our 
mutant. As shown in Fig.10,  the mitochondrial potential as well as the 
sensitivity to menadione, a generator of ROS in the mitochondrial 
compartment, were rescued in pmr1 cells by the increased expression 
of ADH3. However, both the calcium alterations (sensitivity to EGTA) 
and cell wall defects were not suppressed (Fig. 10). 
  
 
 
 
 
Fig. 10 Phenotypes of pmr1 cells overexpressing KlADH3 gene. (A) analysis of the 
mitochondrial functionality by DASPMI; (B) sensitivity to the mitochondrial ROS 
generator, 60 M menadione; (C) the indicated strains spotted on YPD plates with or 
without the calcium chelator, 20mM EGTA; (D)  chitin staining with the fluorescent 
probe CFW. Scale bar for the fluorescent images: 2m. 
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These results suggest that Adh3 has an important role in the 
mitochondrial redox homeostasis of Pmr1-depleted cells. Moreover, we 
can speculate that this enzyme could be a good candidate as GST 
mediator for the recovery of mitochondria defects and further analysis 
will be performed. 
 
 
 
1.8. As in Klpmr1 cells, GST genes are down-modulated 
in HHD keratinocytes 
 
Based on these findings, we extended our study to HHD-derived 
keratinocytes. Thus, we analyzed whether also in HHD cells, like in 
yeast, the loss of pmr1/ATP2C1 induces a down-regulation of 
Glutatione-S Transferase. As shown in Fig. 11 A-B, our analysis 
indicated a decreased expression of GST-T1 and GST-M1 genes in 
HHD lesion-derived keratinocytes compared to non-lesion-derived 
keratinocytes from the same patients (Fig. 11 A-B). GSTs have been 
demonstrated to be important in protecting cells from oxidative stress 
by detoxifying some of the secondary ROS produced when primary 
ROS react with cellular constituents. Additionally, GSTs are 
transcriptionally controlled by NRF2, a transcription factor that 
regulates the expression of many cytoprotective genes implicated in the 
cellular response against oxidative stress. Our results showed that Nrf2 
is down modulated in HHD derived cells (Fig. 11C); thus, indicating a 
mechanism through which GST down-modulation might be established 
in HHD-keratinocytes. 
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Fig. 11 Real-time PCR analysis of gene expression for GST-T1 (A), GST-M1 (B) and 
NRF2 (C) in non-lesional (N) and lesional-skin (L) of three HHD patients (P1-P2-
P3). 
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2. A yeast-based drug screening to identify therapeutic 
compounds for HHD 
 
As mentioned before, currently there is not a specific treatment for 
Hailey Hailey disease. To identify compounds that could prevent the 
HHD manifestation, we initiated a screen for molecules that are able to 
rescue the main phenotypes of the klpmr1∆ mutant. We reasoned that 
the identiﬁcation of positive hits would provide a primary set of 
compounds that can be further tested on human cell culture models of 
Hailey–Hailey disease.  
The initial screening was performed using a set of 131 FDA-approved 
drugs and, for the sake of simplicity, we started evaluating their ability 
to alleviate the cell wall defects of the klpmr1∆ mutant. 
To this aim, the CFW staining was performed on cells grown 24h in the 
presence of the different FDA-approved compounds at the 
concentration of 200 M. The compounds that had partial or not effects 
were tested at the concentration of 250 M. Only the drug S1973 
(Cyclocytidine) had a bigger effect at 250 M than 200M, meanwhile 
the other compounds showed the same phenotype both at 200 and 250 
M. Furthermore, the molecules resulted toxic to 200 M were retested 
at lower concentration (100, 10 and 5 M) but they were discarded 
because still toxic or ineffective. 
At the end of the screening, among the 131 compounds, 6 molecules 
showed at least 40% recovery of cell wall defects of mutant cells.  
Particularly, the compound S2386 strongly recovered the cell wall 
morphology in the 80% of klpmr1∆ cells (Fig. 12A-B).  
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Fig. 12 (A) Pharmacological screening for the recovery of cell wall defects of pmr1 
cells. Mutant strain were grown with individual compounds for 24h and then stained 
with CFW. The six positive hits are shown with wild type cells  used as positive 
control. Scale bar 2 m. (B) Percentage of cells with a WT-like chitin distribution. At 
least 200 cells per sample were scored manually as CFW-recovered or not. 
 
 
 
The six molecules, selected from the preliminary screen, belong to 
different class of drugs (Fig. 13). Indeed, the S2386 and S1973 
(Indirubin and Cyclocytidine) are used in medicine as chemioterapic 
(A) 
(B) 
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(Damiens et al., 2001; Novotný  et al., 1990), the S2387 and S2314 
(Lappaconite Hydrobromide and Kaempferol) have an anti-
inflammatory action (Murota et al., 2002), and S2328 and S2267 
(Nalidixic acid and Azomycin) are mainly recognized as anti-bacterial 
drugs (Bourgnignon  et  al.,  1973; Saeki et al., 1974). 
 
 
 
 
 
 
Fig. 13 Chemical structures of the six natural compounds selected in our 
pharmacological screening 
 
 
 
Our next goal was to assess if these six molecules were also able to 
rescue other defects of the mutant cells, as for example the calcium 
alterations. For this aim, we tested the sensitivity of the klpmr1 cells 
treated with the different drugs to EGTA (Fig.14). In this case two 
compounds had positive effect: S2386 (Indirubin) and S1973 
(Cyclocytidine), meanwhile the other tree molecules had not effects.  
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Fig. 14 Growth of WT and pmr1 cells treated or not with the natural compounds  
onto solid medium supplemented with 20 mM EGTA. 
 
 
 
Since the lack of PMR1 in yeast as well as in human HHD 
keratinocytes, induced an increase of  ROS production (Cialfi et al., 
2010;  Uccelletti et al., 2005), we investigated if the positive hits of the 
primary screen had effects also on the oxidative stress that 
characterized our mutant. The two ROS generators, menadione and 
H2O2 were used to this aim (Fig. 15). While menadione is an 
endogenous generator of ROS, H2O2 is an exogenous one. As shown in 
figure 15 the molecules S2386, S2314 and more effectively the S2387 
and S2267 decreased the growth defects of mutant cells in the presence 
of menadione. Meanwhile S1973 and S2314 resulted more effective 
against H2O2. This indicates that the action of the different compounds 
depends on the localization of the ROS source.  
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Fig. 15 Sensitivity of PMR1-deleted cells, grown with or without the single 
compound, to (A) 60M menadione or (B) 4 mM H2O2. 
 
 
 
Mitochondria are responsible for the main source of ROS in most cells, 
linking mitochondrial respiration with ROS effects on cellular function 
(Murphy, 2009). As showed before, klpmr1∆ cells have an impaired 
mitochondrial functionality with a spotted network compared to a wild 
type tubular one.  For this reason, we evaluated if our selected 
compounds could restore the mitochondrial functionality in the mutant 
strain, using the fluorescent probe DASPMI (Fig 16). We found that 3 
drugs (S2386, S2314 and S2387) restored the tubular mitochondrial 
network of wild type cells. 
 
56 
 
 
 
Fig. 16 Assessment of the mitochondrial functionality for pmr1 cells untreated or 
treated with the indicated drugs. WT strain was used as a control. Scale bar 2 m.  
 
 
 
In conclusion, the data obtained showed that although all the six drugs 
alleviate the cell wall defects of the mutant strain, each of them acts on 
different phenotypes of klpmr1∆ cells. This can agree with the fact that 
the selected molecules belong to different class of drugs (Fig. 13).  
However, the molecular mechanisms by which these compounds 
improve cell survival of the mutant cells still need to be deciphered. 
Moreover, these drugs now need to be validated on human cell-based 
models of Hailey–Hailey disease. 
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DISCUSSION 
 
Yeast is largely used as simple model organism to investigate the 
molecular players associated with  the human diseases. This happens 
because the biological properties of the yeast like rapid growth, the 
ease of  mutant isolation, a well-defined genetic system, and most 
important the fact that  about 30% of the genes known to be involved in 
human diseases have a yeast orthologue (Botstein et al., 1997; Foury, 
1997).   
The recognition that the human orthologue of PMR1 is affected in 
Hailey-Hailey disease inspired yeast researchers to utilize this 
powerful model organism in exploring the pathophysiology and  
potential therapy of this skin disease.  
In S. cerevisiae it has been reported that PMR1-defective cells are 
sensitive to both low and high levels of calcium in the extracellular 
environment (Kellermayer, 2005). The mutant strain has elevated levels 
of cytosolic and total cellular calcium as well as susceptibility to 
manganese and oxidative stress (Halachmi et al., 1996; Lapinskas et al., 
1995). Due to a perturbed ER and Golgi Ca
2+
/Mn
2+
 homeostasis, 
pmr1Δ cells are also defective for protein processing through the 
secretory pathway and are sensitive to ER stress (Park et al., 2001). 
Thus, much of what we know about Hailey-Hailey disease originally 
came from studies in S. cerevisiae.  
Currently, more than 100 mutations in human ATP2C1 suspected to be 
pathogenic in Hailey-Hailey disease have been identified. One obstacle 
that researchers have approaching the HHD-biology is the difficulty in 
obtaining skin samples due to the rarity of HHD and lack of an animal 
model. Moreover, there is no a relevant mammalian Hailey-Hailey 
disease model. Indeed, homozygous mutant mice exhibited no 
manifestations of HHD but did develop squamous cell carcinomas and 
papillomas (Okunade et al., 2007), while occurrences of squamous cell 
tumors is very rare in HHD patients.  
In this study we used the yeast Kluyveromyces lactis as a model to find 
out the molecular basis of HHD. Like S. cerevisiae, K. lactis is 
genetically tractable and the components of human calcium 
storage/handling is conserved. However, K.lactis is a Crabtree-negative 
and obligate aerobe organism that responds to changes in oxygen 
availability like mammalian cells.   
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Based on this similarity between human and yeast calcium handling, 
we performed a genetic screening on K.lactis pmr1Δ cells, with a 
MDCK cDNA library, to isolate possible molecular interactors of 
PMR1/ATP2C1.  
This allowed the identification of GST as a candidate gene associated 
with Hailey-Hailey disease manifestation. Indeed, from the genetic 
screening we selected one positive clone that was able to grow in the 
presence of hydrogen peroxide. After the sequencing, we found that the 
cDNA encoded the Glutathione S-transferase belonging to the Tetha 
class. Glutathione S-transferases (GSTs) are important in the 
detoxification of many compounds, including reactive oxygen species. 
The reduced and oxidized forms of glutathione (GSH and GSSG) act in 
concert with other redox-active compounds (e.g., NAD(P)H) to 
regulate and maintain cellular redox status. GSH, which is the main 
antioxidant in yeast (Lushchak, 2012), is used by GSTs to protect cells 
against toxicants by conjugating the thiol group of the glutathione to 
electrophilic xenobiotics, and thereby defend cells against the 
mutagenic, carcinogenic, and toxic effects of the compounds.  
We found that in the pmr1Δ mutant, GST expression is decreased 
compared to WT and this would render this strain less tolerant to 
cellular stress and consequently would influence cell viability. 
Increased levels of ROS is a hallmark of both keratinocytes derived 
from HHD lesions and yeast pmr1 cells. The results that we obtained 
further demonstrate the importance of oxidative stress for pmr1 
phenotypes and indicate the role for GST in protecting cells against 
oxidative damage; it can be inferred that ROS detoxification represents 
its main effect.  
Moreover, we can speculate that GST might affect the redox status of 
Calcineurin and increase its anti oxidative stress function. It has been 
described that oxidative stress is a very potent CN inhibitor, acting by 
altering the redox state of iron at the CN active site. Interestingly, CN 
activity decreased in cells that were treated with L-buthionine-(S,R)-
sulfoximine, an inhibitor of synthesis of the antioxidant glutathione 
(Alba et al., 2012).  
In this context, decreased GST activity in PMR1-deleted strain would 
influence cell response to oxidative stress.  
Furthermore, here we demonstrate the importance of CN-dependent 
GST activity for protection against oxidative stress. Indeed, we found 
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that pmr1cnb1  double mutant was hypersensitive to exogenous 
stress, and GST overexpression was unable to restore cytosolic Ca
2+
 
levels as well as tolerance to exposure to either H2O2 or EGTA and cell 
wall defects.  Ca
2+
 overload as well as oxidative stress might lead to 
altered mitochondrial morphology through a CN-dependent 
mechanism. However, after overexpression of GST in pmr1cnb1 
double mutant mitochondrial tubular morphology is restored. The 
suppression of mitochondrial phenotype indicates that GST exerts a 
direct effect on the mitochondria morphology independently of CN 
signaling.  
Our data, demonstrating that GST-mediated activity is an essential 
mechanism for maintenance of the mitochondrial functionality, is 
supported by the finding that altered GST activity results in increased 
mitochondrial stress and increased ROS production (Zhang et al., 
2012).  
Moreover, preliminary data suggest that the metabolic enzyme Adh3 
could help the glutathione S-transferase in the recovery of the 
mitochondrial defects of pmr1 cells. Indeed we found that the activity 
of this alcohol dehydrogenase was particularly higher in the mutant 
cells overexpressing GST. Furthermore, this hypothesis was supported 
by the findings that the overexpression of K. lactis ADH3, in PMR1-
deleted cells, restored the functionality of mitochondria and reduced the 
sensitivity to menadione, that selectively increases the ROS production 
at the mitochondrial level.  
In order to validate the observations gathered from yeast, the analysis 
was extended to HHD-derived keratinocytes. Our findings showed that, 
as in pmr1 yeast mutant, HHD-lesion-derived keratinocytes were 
characterized by decreased expression of GST genes compared to non-
lesion-derived keratinocytes from the same patients. The activities of 
GSTs, like other antioxidant enzymes, are controlled at transcriptional, 
translational, and posttranslational levels. In animals, the activities of 
many phase II detoxifying enzymes, including GSTs and Glutathione 
peroxidases (GPxs), are upregulated via the Nrf2/Keap1 system via 
interaction with antioxidant response elements (ARE) in the regulatory 
regions of many of these genes (Itoh et al., 1997; McMahon  et al., 
2001). Consistent with reduced GST-T1 and GST-M1 expression, we 
observed a decrease expression of the transcriptional factor NRF2 in 
HHD-lesion-derived keratinocytes.  
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In conclusion, the Glutathione S-transferase theta subunit was 
identified by a yeast genetic screening as a suppressor of the oxidative 
stress taking place in cells lacking the Golgi Ca
2+
/Mn
2+−ATPase. In 
both yeast and HHD-derived keratinocytes, a down regulation of the 
corresponding GST genes was found, showing as K.lactis can be a 
model system for further investigation of the molecular mechanisms 
underlying this skin disorder. 
 
To date, a real cure for HHD is absent and the treatment of HHD 
patients is mainly focalized on antifungal, antibiotic or antiviral to 
reduce the secondary infections (Burge, 1992; Le Saché-de Peufeilhoux 
et al., 2012)  and corticosteroids to reduce inflammation (Ikeda et al., 
1993). Other treatments aim to prevent the disease-triggering factors 
such as exposure to sunlight, friction or skin sweating. An example for 
the latter is the use of Botulinum toxin to reduce sweating and limiting 
the outbreak of HHD (Bessa et al., 2010). Reports of drug with positive 
effects on HHD lesions exist but they are mainly based on case studies. 
These reports include photodynamic treatment (Ruiz-Rodriguez et al., 
2002) or the topical application of active compounds, like 
Aminoglycosides and vitamin D3 derivates (Clancy  et al., 2001;  Aoki  
et al., 1998), but a validated cure for all the patients is still faraway. 
Following the large use of yeast as a powerful model for human 
diseases, it is widely recognized that yeast-based pharmacological 
screenings provide greater ease of genetic manipulation and it can be 
made rapidly at low cost. 
This is more relevant in the case of HHD due to the lack of good 
animal models. Thus, we established a yeast-based screening assay 
designed to identify drugs that could be active against Hailey Hailey 
disorder.  
For the sake of simplicity, in the initial screening, we tested 131 FDA-
approved natural compounds for their ability to suppress the cell wall 
defects of the pmr1Δ mutant. This primary screen allowed the 
identification of six positive hits: Indirubin (S2386), Cyclocytidine 
(S1973), Nalidixic acid (S2328), Azomycin (S2267), Kaempferol 
(S2314) and Lappaconite Hydrobromide (S2387). As mentioned 
before, the six compounds belong to different classes of drugs. Indeed, 
Indirubin and Cyclocytidine are chemioterapics, Kaempferol and 
Lappaconite Hydrobromide have anti-inflammatory action, Azomycin 
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and Nalidixic acid are commonly used for their anti-bacterical action. 
This could explain because we observed that some compounds are 
active on different phenotype of our mutant. 
In our screening, the less effective drug resulted  the Nalidixic acid that 
is able to recover only the cell wall defect of pmr1 cells. This drugs is 
an anti-microbic agent described as a specific  inhibitor  of  bacterial  
DNA  synthesis  in  vivo  and  in vitro  (Bourgnignon  et  al., 1973), 
besides it also prevents protein synthesis in eukaryotic organisms, such 
as S. cerevisiae (Whittaker and Carnevali 1977). It is reported that the 
ability of S. cerevisiae cells, treated with pulsed electric fields (PEF), to 
repair the membrane damage in the presence of Nalidixic acid  would 
require, to some extent, nucleic acid or protein synthesis (Somolinos et 
al., 2008). Although the effects of Nalidixic acid on cell wall are 
unknown, we  speculate that also in the recovery of cell wall defects of  
our mutant, Nalidixic acid could act on the nucleic acid or protein 
synthesis. 
In the next step of the screening, we evaluated whether the six selected 
compounds were able to affect other phenotypes of PMR1-deleted 
cells. We found that the growth of pmr1 cells on Ca2+ chelator, 
EGTA, was recovered only by the two chemioterapic compounds 
Cyclocytidine and Indirubin. 
Cyclocytidine is the prodrug of cytarabine, which is a pyrimidine 
nucleoside analog that inhibits the DNA synthesis and used mainly in 
the treatment of leukemia (Novotný et al., 1990). 
It displayed selective growth inhibition against the tumor cell lines with 
ras oncogenes that is the most frequently occurring gain-of-function 
mutation detected in human tumors (Koo et al., 1996). 
Instead, Indirurbin is a red colored  3,2-bisindole isomer and one of the 
component of Indigo naturalis, as well as an active ingredient used in 
traditional Chinese medicine for the treatment of chronic diseases. It 
selectively inhibits CDKs and other kinases like GSK-3 blocking 
cancer cell proliferation in the late G1 and G2/M phases of the cell 
cycle (Damiens et al., 2001). 
Since K. lactis cells lacking of the Ca
2+
/Mn
2+
-ATPse present also 
alterations in the cell cycle (Uccelletti et al., 1999), probably Indirubin 
and Cyclocytidine  act on determinate components of cell cycles thus, 
in some way, they restore the growth of mutant cells in the presence of 
EGTA.  
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We also investigated the ability of the selected drugs to alleviate the 
oxidative stress of pmr1cells. To understand if the drugs effects could 
be influenced by the source of ROS, we used menadione and H2O2, 
generating ROS at mitochondrial and extracellular level respectively.  
Indeed, Indirubin, Azomycin, Lappaconite Hydrobromide and 
Kaempferol acted on the mitochondrial-derived ROS, recovering the 
growth on menadione; meanwhile Cyclocytidine and Kaempferol 
allowed PMR1-deleted cells to grow in the presence of H2O2.  
Azomycin is an antimicrobial antibiotic produced by a strain of 
Nocardia mesenterica. It was studied  its biochemical effect mostly on 
Bacillus subtilis and Escherichia coli in which  inhibits the activity of 
ribonucleotide reductase involved in the nucleic acid synthesis (Saeki et 
al., 1973). 
Lappaconite Hydrobromide is instead a kind of alkaloid extracted from 
Aconitum sinomontanum Nakai and has anti-inflammatory effects. For 
both Azomycin and Lappaconite few is known about the mechanism of 
action and further analysis are necessary to understand their role in the 
oxidative stress response. 
Very interesting the flavonoid, Kaempferol, recovered the growth on 
both menadione and H2O2, showing a broader spectrum of action agaist 
ROS. However, the antioxidant properties of Kaempferol  are well 
know. Indeed, it exhibits strong radical-scavenging activity (Murota et 
al., 2002), inhibits formation of superoxide anion radicals by xanthine 
oxidase (Selloum et al., 2001) and  reduces  the damage to DNA 
induced by H2O2 (Noroozi et al., 1998). In the nematode C. elegans 
Kaempferol reduces the ROS boost induced by thermal stress and 
prolonged the survival at lethal temperature  inducing the nuclear 
localization of the FoxO transcription factor, DAF-16 (Kampkötter et 
al., 2007). Moreover in human keratinocyte cell line, HaCaT, 
Kaempferol  controls the transcription of several genes by the 
regulation of key transcriptional factor involved in the oxidative stress 
and inflammation like Nrf-2 and Nf- κB (Kang et al., 2008). Finally 
analyzing the mitochondrial functionality of pmr1 cells treated with 
the six drugs we found that while Indirubin and Lappaconite 
Hydrobromide partially recovered the ∆Ψ alteration of mutant strain, 
Kaempferol totally restored a mitochondria WT-like tubular network.  
Nothing is reported about the role of Lappaconite Hydrobromide on 
mitochondrial membrane potential; while, Varela and colleagues 
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demonstrated that, in the isolated rat liver mitochondria, Indirubin 
derivative indirubin-3’-oxime impairs the oxidative phosphorylation 
but on the other hand, it had a partial preventive role on the 
mitochondrial permeability transition induced by calcium overload 
(Varela et al., 2008). In the same way in the pmr1 mitochondria, 
Indirubin could partial recover the membrane potential alterations 
caused  by the loss of the Ca
2+
 pump.  
The protective role of Kaempferol on mitochondria is well reported in 
literature. Indeed Choi in 2011 demonstrated that pre-treatment with 
Kaempferol reduced the mitochondrial membrane potential dissipation 
as well as the ([Ca2+]i) elevation, and ROS production in osteoblast-
like MC3T3-E1 cells treated with antimycin A (Choi, 2011). 
Furthermore, mitochondrial Ca
2+
 uptake is  enhanced by treatments 
with Kaempferol (Montero et al., 2004; Kannurpatti et al., 2015 ) 
indicating a regulation of  mitochondrial Ca
2+
 homeostasis by 
Kaempferol. Thus, in PMR1- deleted cells  Kaempferol could restore 
the mitochondrial functionality by scavenging the ROS and controlling 
Ca
2+
 levels of the organelle. 
In conclusion, our screening allowed the identification of six 
compounds able to alleviate one or more phenotypes of pmr1 cells. 
The most promising molecules resulted the indol Indirubin and the 
flavonoid Kaempferol.   
However, further analysis are necessary to understand the mechanisms 
of action and the possible molecular targets of these compounds. 
Lastly, these drugs will be tested in human cell-based  models of 
Hailey–Hailey disease  to be validated. 
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WORK IN PROGRESS 
 
1. C. elegans: a simple multicellular model to study 
HHD 
 
As shown before, in HHD keratinocytes, the transcription factor Nrf2 is 
down modulated.  In order to study the involvement of this factor in the 
phenotypes associated to the pathology, we decided to consider another 
simple organism, largely utilized for modeling human diseases: the 
nematode Caenorhabditis elegans. This choice was mainly due to the 
lack of NRF2 in yeast cells. 
The roundworm C. elegans is a free-living, non-parasitic nematode, 
with a life cicle of 3.5 days at 20°C and a lifespan of about 2–3 weeks 
under suitable living conditions. Hatched animals develop through four 
larval stages (L1–L4) to arise as an adult hermaphrodite with 959 
somatic cells (Sulston and Horvitz, 1977) and a body length of about 1 
mm and 80 μm in diameter (Fig. 1).  
 
 
 
 
Fig. 1 C. elegans life cycle. Under favorable conditions animals pass through direct 
development to adulthood in as little as 3 to 4 days. In response to hard environmental 
conditions, like  food shortage, crowding or high temperatures, animals can enter into 
an arrested dauer stage (Murgatroyd and Spengler, 2010). 
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This simple metazoan can be easily cultivated in large numbers and the 
transparent body permits to track cells and follow cell lineages and 
biological processes (Sulston et al., 1983). In 1998 the whole genome 
of C. elegans was sequenced  and it has been estimated that about 42% 
of the human disease genes have an orthologue in the C. elegans 
genome. 
At the beginning, a RNAi clone to inactivate pmr-1 was constructed 
(see materials and methods) and the effects of pmr-1 inactivation was 
evaluated in terms of EGTA sensitivity. To this aim, a lifespan assay 
was performed using L4 one day-adult animals interfered for 48h with 
pmr-1(RNAi) or with E. coli transformed with the empty plasmid, EV 
(RNAi), and then supplemented continuously with 20mM EGTA. As 
shown in the Fig 2, the EGTA treatment induced a strong reduction of 
the survival rate of pmr-1 worms when compared to the control animals 
(Fig. 2). 
 
 
 
Fig. 2 Lifespan analysis of N2 animals fed with EV(RNAi) or pmr-1(RNAi). L4 one 
day-adult animals, after 48h of interference, were shifted on RNAi plates supplied 
with 20mM EGTA (To). From this point, the worms were interfered and treated with 
EGTA continuously during the life span. The untreated  animals (NT) were used as a 
control. n=50 for each data point of single experiment.  
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Moreover, we investigated if the Nrf2-homolog gene, skn-1, was down-
modulated in PMR-1 depleted worms, as for the mammalian 
counterpart in HHD keratinocytes. For this aim, we used a transgenic 
strain (LD1) homozygous for a reporter gene (ldls7), which consists of 
a fusion of the skn-1b/c promoter to GFP (skn1::GFP).  
Transgenic one day-adult worms were fed with EV (RNAi) or pmr-1 
(RNAi) for 48h or 72h and then the fluorescence was analyzed. The 
results obtained indicated that, also in C. elegans, the transcriptional 
factor NRF2/SKN-1 is down-modulated; indeed the GFP fluorescence 
was lower in the pmr-1 worms when compared to the control (Fig. 3).  
 
 
 
 
 
Fig. 3 skn-1::GFP expression in LD1 worms treated with EV(RNAi) or pmr-1(RNAi) 
for 48h or 72h. The pictures were taken at the X5 magnification; scale bar 100M  
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Thus, when ATP2C1/PMR-1 is not expressed, the down-modulation of 
NRF2/SKN-1 occurs in both HHD keratinocytes and the nematode C. 
elegans. 
However, these preliminary data need to be widened by further 
experiments. We are currently investigating the role of key players 
involved in the pathways those cross-talk with SKN-1, such as the 
insulin/IGF-1 receptor, DAF-2, and the FOXO transcription factor, 
DAF-16 (Fig.4).  
 
 
 
 
  
Fig. 4 Molecular interaction of SKN-1 with the DAF-2 and DAF-16 pathways 
(Lapierre and Hansen, 2012). 
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MATHERIALS AND METHODS 
 
1. Yeast strains and growth conditions 
 
The strains used in this study were MW278-20C (MAT 
a,ade2,leu2,uraA) and CPK1 (MAT a,ade2, leu2, uraA, PMR1::KanR).  
The centromeric Kcplac13 plasmid harboring the KlADH3 ORF (kindly 
provided by Dr. Michele Saliola ) was used to overexpress the K. lactis 
Alcohol dehydrogenase 3 in the pmr1 cells. 
The double mutant pmr1cnb1 was obtained by transforming the 
CPK1 strain with the disruption cassette for CNB1. The deletion 
cassette was obtained by cloning the 5’ and 3’ regions of CNB1, 
amplified with the following primers (5’CnbF 5’ 
TGTTCAACCACGAGCATAAAA-3’; 5’CnbR 5’-
CCTCTTCCACTGAAGATGGAT-3’; 3’CnbF 5’-
CGGTTACATATCCAATGGTGA-3’; 3’CnbR 5’-
CGTCAATGCCAGAGAAAACA-3’), in the TA vector (Invitrogen). 
Afterward these fragments were subcloned in pKSURA3 carrying the 
URA3 gene of S. cerevisiae. After amplification of the disruption 
cassette with the above mentioned 5’CnbF and 3’CnbR primers, the 
MW278-20C strain was transformed and the transformants were 
selected on synthetic complete (SC) media without uracil and then 
analyzed by PCR to test the correct integration of the cassette. 
Yeast strains were grown in SD minimal medium (2% glucose, 0.67% 
yeast nitrogen base without amino acids) with the appropriate 
auxotrophic requirements. Five-fold serial dilution from concentrated 
suspensions of exponentially growing cells (5 × 10
6
 cell/ml) were 
spotted onto synthetic YPD agar plates (1% yeast extract, 1% peptone, 
2% glucose, 2% agar) supplemented or not with 4 mM H2O2. The 
plates were incubated at 30°C for 3 days. 
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2. Screening of MDCK cDNA library 
 
The CPK1 strain was transformed to saturation with the MDCK cDNA 
library constructed in the 
pEPGK31 multicopy vector (kindly provided by Dr. Claudia Abeijon) 
by electroporation. All the Ura
+
 transformants were replica plated on to 
YPD medium supplemented with 4 mM H2O2. 
The plasmids isolated from the Ura
+
/ H2O2 transformants were used to 
transform the pmr1Δ strain. Plasmids capable of restoring the H2O2 
phenotype to the pmr1Δ after retransformation were analyzed. 
Molecular analysis by restriction enzymes of the DNA fragments from 
the isolated plasmids showed that one of these plasmids carrying a 
fragment of about 800 base pairs (bp) was able to restore the H2O2 R  
phenotype and then was sequenced (BMR Genomics). Afterward, the 
fragment resulted to be the cDNA of the GST theta class and it was 
subcloned into the multicopy 
vector pCXJ6-L (Zanni et al., 2009) to obtain the pGST plasmid. Yeast 
strains were then transformed with pGST plasmid or the empty vector 
pCXJ6-L, used as a control. In the case of GTT1 expression, the K. 
lactis gene was cloned in p426SD11 vector by amplifying the ORF 
with the following primers: GTT1orf_F 5’–
CGGGATCCTCAGATACACGCATCCCAC-3’ and GTT1orf_R 5’– 
CTCGAGGAATGAGGCGCCATTCGCTT-3’ (the BamHI and XhoI 
restriction sites are single and double underlined, respectively). The 
PCR product was ligated into the pGEM-T-Easy vector  (Promega) and 
after sequencing (MWG Biotech, Ebersberg, Germany) the fragment 
was cloned in BamHI/XhoI-digested p426SD11 plasmid, obtaining 
pGTT1 vector. 
 
 
 
3. Fluorescence microscopy 
 
Late exponential-phase cells grown in SD minimal medium were 
harvested, washed with water and then incubated with the vital dye 2-
(4-dimethylaminostyryl)-N-methylpyridinium iodide (DASPMI; 
Sigma) by the method of (Guthrie and Fink, 2002). Chitin staining was 
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performed by the method of (Uccelletti et al., 1999). Epifluorescence 
microscopy was carried out with a Zeiss AxioVert 25 microscope fitted 
with a ×100 immersion objective and a standard filter set. 
 
 
 
4. Cytofluorimetric analysis 
 
To evaluate the ROS accumulation, 10
8
 cells were harvested and 
washed twice in PBS and then  were incubated in PBS at 28°C with 
Dihydroethidium (DHE) for 10 min. After the incubation, the cells 
were washed three times in PBS and then were analyzed. To measure 
the intracellular Ca
2+
 levels, 10
8
 yeast cells, harvested and washed 
twice in PBS, were incubated in PBS at 37°C for 30 min with 10 μM 
Fluo-3-acetoxymethyl ester (Fluo-3/AM; LifeTechnologies). A non-
cytotoxic detergent, pluronic F-127 (0.1%), was added to increase 
solubility of the Fluo-3/AM. Then yeast  cells were washed twice in 
PBS and analyzed. Fluorescence was measured by Becton-Dickinson 
FACSCalibur flow cytometer. 
 
 
 
5. Quantitative Real-time PCR from yeast cells 
 
RNAs were extracted through the hot phenol method as described in 
(Zanni et al., 2015) and then digested with 2U/μl DNAse I (Ambion). A 
total of 1 μg of each sample were reverse-transcribed using oligo dT 
and SensiFAST cDNA Synthesis Kit (Bioline), according to the 
manufacturer's instructions. The  cDNA than was diluted at final 
concentration of 20 ng/l. Real-time PCR was performed using 
SensiMix SYBR (Bioline) and selective primers (200 nM) designed 
with Primer3 software (Table  S1). Each well contained 2μl of cDNA 
used as template and all samples were run in triplicate. An I Cycler 
IQ™ Multicolor Real-Time Detection System (Biorad) was used for 
the analysis. Real-time PCR conditions included a denaturing step at 
95°C for 3min, followed by 40 cycles at 95°C for 30s, 55°C for 30s and 
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75°C for 45s. Two cycles were included as final steps: one at 95°C (1 
min) and the other at the annealing temperature specific for each couple 
of primers used (1 min).  
Quantification was performed using a comparative CT method 
(CT=threshold cycle value). Briefly, differences between the mean CT 
value of each sample and the CT value of the housekeeping gene 
(ACT1) were calculated: ΔCTsample=CTsample−CT ACT1.  
The final result was determined as 2
−ΔΔCT
 where 
ΔΔCT=ΔCTsample−ΔCTcontrol. 
 
 
 
 
Table S1: Primer sequences used in the yeast real-time PCR experiments. 
 
 
 
6. EGTA challenge assay 
 
Cells grown until late exponential phase were challenged with 20mM 
Ethylene glycol-bis (2- aminoethylether) -N,N,N2,N2-tetraacetic acid 
(EGTA) for 6h. Afterwards, aliquots of the cells were withdrawn, 
diluted and plated on agar plates. EGTA sensitivity was assessed by 
CFU counting method and results were expressed as percentage of cell 
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survival with respect to untreated samples. The data are the mean of 
three different experiments. 
 
 
 
7. ADH activity analysis  
 
Yeast cells were grown to the early stationary phase in 10 ml of SD 
medium supplied with the appropriate auxotrophies. Cells were broken 
with glass beads in Eppendorf  tubes, centrifuged and the supernatants 
were analyzed by electrophoresis on non-denaturing 5% acrylamide 
gel. 
ADH isozymes were revealed by incubating the gels for 1 hr at 23° C 
in the dark with a mixture containing 0.5 M ethanol; 7 mg/ml NAD; 25 
g/ml phenazine methosulfate (Sigma); 1 mg/ml nitroblue tetrazolium 
chloride in 60 mM pyrophosphate buffer, pH 8.8.  
The activity of the Glucose-6-Phosphate Dehydrogenase (G6PDH), 
used as positive control, was visualized by incubating the  gel for 10 to 
15 min in 5 ml of the following solution: 10 μl of 1 M MgCl2, 50 μl of 
NADP (100 mg/ml in 100 mM Tris-HCl, pH 8.0), 15 μl of phenazine 
methosulfate (40 mg/ml in H2O) (Sigma), 30 μl of nitroblue tetrazolium 
salt (50 mg/ml in H2O) (Sigma), 25 μl of glucose-6-phosphate (100 
mg/ml in H2O), and H2O to a final volume of 5 ml. 
 
 
 
8. Quantitative Real-time PCR from keratinocytes 
 
Total RNA from primary cells was extracted using Trizol Reagent 
(Thermo Fisher Scientific, MA, USA) according to manufacturer’s 
instructions. Reverse transcription (RT) of total RNA was performed 
using High capacity cDNA Reverse transcription kit as previously 
described (Cialfi et al., 2013) (Thermo Fisher Scientific, MA USA) and 
according to manufacturer’s instructions. Quantitative Real time PCR 
(qRT-PCR) for GST-M1, GST-T1 and NRF2 expression analysis were 
carried out using specific primers indicated in Table S2 with 
SensiFAST SyBr Hi-ROX kit (Bioline, UK) or with specific TaqMan 
MGB primers/probe using Taqman gene expression assay (Thermo 
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Fisher Scientific, MA USA). GAPDH mRNA was used as endogenous 
control to normalize sample data. The 2
-CT
 method was used to 
calculate the relative mRNA amount of lesion compared to not lesion 
sample represented as unitary value. 
 
 
Table S2: Primes used for the qRT-PCR 
 
 
 
9. Screening of an FDA-approved compound library 
 
A library of 131 FDA-approved drugs was purchased from Selleck 
Chemicals (Houston, TX, USA). Compounds were stored as 10 mM 
stock solutions in dimethyl sulfoxide (DMSO) at -20°C until use. 
Compound stocks were diluted to the utilized concentration in the 
growth YPD medium. After 24h of growth at 28°C the cells were 
harvested and prepared for the CFW or DASPMI staining. 
Alternatively, for the sensitivity tests,  yeast strains were grown for 24h 
in the YPD medium; than five-fold serial dilution from concentrated 
culture were spotted onto synthetic YPD agar plates supplemented or 
not with 20mM EGTA or 4mM H2O2 or 60 M menadione . The plates 
were incubated at 30°C for 3 days.   
 
74 
 
10. Worm strains and media 
The worm strains used in this work are the standard wild type N2 
(Bristol) and LD1 [ldIs7{Pskn-1::skn-1B/C::GFP+pRF4(rol-
6(su1006))}], purchased from the Caenorhabditis Genetics Center 
(CGC). 
Worms were grown on Nematode Growth Media (NGM) plates at 
20°C. NGM contains: 3 g/L NaCl, 17 g/L agar, 2.5 g/L peptone, 1 ml/L 
cholesterol (5 mg/ml in 95% EtOH), 1 ml/L 1 M CaCl2, 1 ml/L 1 M 
MgSO4, 25 ml/L 1 M KH2O4  buffer pH 6. The plates were dried and  
E. coli OP50 strain was spread to serve as worm food. Seeded plates 
were incubated at 37°C overnight and used after a time of about 30 min 
at room temperature.   
 
 
 
11. Construction of the RNAi strains 
 
Based on the nucleotide sequence of ZK256.1c (Chromosome I: 
13004437-13023625; Worm Base), forward (CEf 5’-
CCGCCAATTCACAGTTTGGA-3’) and reverse (Cer 5’-
CATTCTGCCCATGTGCATCA-3’) primers were designed to amplify 
a pmr-1 fragment from genomic DNA by PCR, using the BIOTAQ 
DNA polimerase (Bioline). The PCR product was ligated into the 
pGEM-T-Easy vector  (Promega) and controlled by EcoRI (Roche) 
digestion. After sequencing (MWG Biotech, Ebersberg, Germany) the 
pmr-1 ORF was cloned in XbaI/PstI -digested L4440 double promoter 
vector (Timmons et al., 2003), to generate a pmr-1 double-strand RNA 
(dsRNA) expression plasmid (L4440-pmr-1). The resulting plasmid 
was used to transform the HT115(DE3) RNase Ill-deficient E. coli 
strain, which was shown to be beneficial for RNAi by feeding  
(Timmons and Fire, 1998). Moreover the HT115 E. coli strain 
transformed with the “empty” L4440 vector  was used as control in the 
RNAi expreriments. 
The HT115 genotype is the following: (F
-
, mcrA, mcrB, IN(rrnD-
rrnE)1, lambda
-
, rnc14::Tn10(DE3 lysogen:lacUV5 promoter-T7 
polymerase)). The RNase III gene is disrupted by a Tn10 transposon 
carrying a tetracycline-resistance marker.  
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12. Preparation of RNAi plates 
 
Single colonies of HT115 bacteria transformed with the plasmid were 
picked and grown overnight at 37°C, supplemented with 50 g/ml 
Ampicillin and 12,5 g/ml Tetracycline. Afterward, 1ml of overnight 
cultures was inoculated in 100 ml of Luria-Bertani (LB) broth 
supplemented with 50 g/ml Ampicillin and incubated at 37°C to 
OD600=0,4; then 0,4 mM IPTG was added to the cultures for 3h. 
When the induction time finished, the culture were pulled down by 
centrifugation, resuspended in 2 ml of distillated water, spread on 
RNAi NGM plates and then left at 37°C overnight.  
The RNAi NGM plates contain 3 g/L NaCl, 17 g/L agar, 2.5 g/L 
peptone, 1 ml/L cholesterol (5 mg/ml in 95% EtOH), 1 ml/L 1 M 
CaCl2, 1 ml/L 1 M MgSO4, 25 ml/L 1 M KH2O4  buffer pH 6, 0,4 mM 
IPTG, 50 g/ml Ampicillin, 12,5 g/ml Tetracycline. 
 
 
 
13. Life span analysis 
 
The life span assays are performed at 20°C  with  synchronized L4 
wild-type worms fed on bacteria expressing pmr-1 RNAi or the empty 
vector EV (RNAi) for 48h. After this time, the animals were shifted on 
RNAi plates containing 20 mM EGTA, and thus the life span started 
(To).  The worms were transferred to fresh plates and monitored daily. 
The nematodes were scored as dead when they no longer responded to 
gentle prodding with a platinum wire. Animals that crawled off the 
plates were not included in the analysis.  
 
 
 
14. Worm imaging 
 
Synchronized LD1(skn-1::GFP) worms at the stage of one day-adult 
were fed with EV(RNAi) or with pmr-1(RNAi) for 48h and 72h.  
Besides, to remove the bacteria on the animal body the worms were 
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washed twice with M9 buffer (3g/L KH2PO4, 6 g/L Na2HPO4, 5g/L 
NaCl, 1 ml 1M 1 M MgSO4 dissolved in distillated water). Microscopy 
images were taken mounting the washed animals on a 3% agarose plus 
20 mM sodium azide pad on a microscopic glass slide and observed 
with a Zeiss Axiovert 25 microscope. 
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